Safety-Smoked Cannabis 2015-2020

STUDIES ON CONDITIONS and RELATED ARTICLES 2015-2020

*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000-2009 List
^Articles/Studies in 2010-2014 List
>Information in Another Section

SAFETY AS A SUBSTANCE-NATURAL CANNABIS*+
SAFETY AS A SUBSTANCE–NATURAL CANNABIS–ADVERSE REACTIONS
SAFETY AS A SUBSTANCE–SYNTHETICS
SAFETY-ADULTERANTS/CONTAMINANTS*+
SALIVARY GLANDS/SALIVA
>SCHINZEL-GIEDION SYNDROME (See News Articles 2010-2018)
SCHISTOSOMA INFECTION+
SCHIZOPHRENIA/MENTAL DISORDERS*+
SCHWANNOMATOSIS (Genetic Disorder with Multiple Benign Tumors called Schwannomas, which Grow on Peripheral Nerves and the Spinal Cord)
SCIATIC NERVE INJURY

SCLERODERMA/SYSTEMIC SCLEROSIS+
SEBACEOUS GLANDS+ (Produce Skin Oils)
SEBORRHEA
SEPTIC SHOCK/SEPSIS*+
SEX-BASED DIFFERENCES*+

SEXUAL ABUSE

SEXUAL MINORITIES
>SHINGLES (See News Articles 2010-2018)

SICKLE CELL DISEASE+
>SINUSITIS (See also 2000-2009)
SKIN

SLEEP APNEA+
SLEEP DISORDERS/PARASOMNIAS (Sleep Walking, Sleep Paralysis, Night Terrors etc. See also NIGHTMARES)

SLEEPING SICKNESS/TRYPANOSOMIASIS*^ (See Also CHAGAS DISEASE)
SLEEP MODULATION*+
SMALLPOX+ (See Also COW POX [not good news])
SMELL/OLFACTORY SYSTEM/ODOR DETECTION+
top


SAFETY AS A SUBSTANCE-NATURAL CANNABIS*+
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. (Canada/ Germany) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
State Estimates of Adolescent Marijuana Use and Perceptions of Risk of Harm From Marijuana Use: 2013 and 2014. (USA) (full – 2015) http://www.samhsa.gov/data/sites/default/files/report_2121/ShortReport-2121.html
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product — Colorado, March 2014. (USA) (full – 2015) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a6.htm
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development. (United Arab Emirates/ India/ USA/Saudi Arabia) (full – 2015) http://www.hindawi.com/journals/ecam/2015/238482/
Mull it over: cannabis vaporizers and harm reduction. (Australia) (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13139/full
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Cannabinoids in the management of chronic pain: a front line clinical perspective. (Canada) (full – 2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0059/jbcpp-2015-0059.xml
Vaping cannabis (marijuana): parallel concerns to e-cigs? (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860523/
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361312/
Cannabis Allergy: What do We Know Anno 2015. (Belgium) (full – 2015) http://link.springer.com/article/10.1007%2Fs00005-015-0352-z
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/
Responsible and controlled use: Older cannabis users and harm reduction. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499492/
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9- tetrahydrocannabinol in older persons with dementia. (Netherlands) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480847/
Marijuana: A Time-Honored but Untested Treatment for Epilepsy (Canada) (full–2015) https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/div-classtitlemarijuana-a-time-honored- but-untested-treatment-for-epilepsydiv/DDEDDD9EAA09918D3D69CC7CA047AE5C/core-reader Phytocannabinoids and epilepsy. (Brazil) (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Cannabinoids and Epilepsy. (Brazil) (full – 2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
Safety of oral dronabinol during opioid withdrawal in humans. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663169/
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. (USA) (full – 2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A systematic review of randomized controlled trials. (Canada/ Germany/ USA) (full – 2015) http://onlinelibrary.wiley.com/doi/10.1002/acr.22727/full
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). (Canada) (full – 20 15) http://www.jpain.org/article/S1526-5900(15)00837-8/fulltext
Cannabis in medicine: a national educational needs assessment among Canadian physicians. (Canada) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374299/
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials. (Canada) (link to PDF – 2015) https://www.researchgate.net/publication/273888773_Cannabinoids_for_the_Treatment_of_Chronic_Non-Cancer_Pain_An_Updated_Systematic_Review_of_Randomized_Controlled_Trials
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses. (Brazil) (link to PDF – 2015) https://www.researchgate.net/publication/271334260_Role_of_endocannabinoid_signalling_in_the_dorsolateral_periaqueductal_grey_in_the_modulation_of_distinct_panic-like_responses
Did we have the wrong debate about Elixinol™ and medicinal cannabis? (New Zealand) (link to PDF – 2015) https://www.nzma.org.nz/journal-articles/did-we-have-the-wrong-debate-about-elixinol-tm-and-medicinal-cannabis
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. (UK) (click “psuedu” for download–2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Risk+of+emergency+medical+treatment+following+consumption+of+cannabis+or+synthetic+cannabinoids+in+a+large+global+sample.&btnG Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (USA) (click “researchgate” for download– 2015) https://scholar.google.com/scholar?cluster=5587800066287982849&hl=en&as_sdt=0,5&as_vis=1&scioq=%22Cannabidiol+in+patients+with+treatment-resistant+epilepsy:+an+open-label+interventional+trial%22
Half-Baked — The Retail Promotion of Marijuana Edibles. (USA) (article – 2015) http://www.nejm.org/doi/full/10.1056/NEJMp1416014
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut. (USA) (article – 2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
How beneficial is vaping cannabis to respiratory health compared to smoking? (USA) (article – 2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Peaceful feeling, or up in smoke? Medical marijuana in medicolegal context. (USA) (article – 2015) http://www.beyondthebrain.net/blog/peaceful-feeling-or-up-in-smoke-medical-marijuana-in-medicolegal-context
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (USA) (letter – 2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
st The cannabis conundrum: Thinking outside the THC box. . (USA) (1 page – 2015) https://accp1.onlinelibrary.wiley.com/doi/abs/10.1002/jcph.511
Prescribing medical cannabis in Canada: Are we being too cautious? (Canada) (abst – 2015) https://link.springer.com/article/10.17269%2Fcjph.106.4926
(1st page – 2015) https://www.questia.com/read/1P3-3836821201/prescribing-medical-cannabis-in-canada-are-we-being
Change in perceived risk associated with marijuana use in the United States from 2002 to 2012. (USA) (abst – 2015) https://www.semanticscholar.org/paper/Change-in-perceived-risk-associated-with-marijuana-Okaneku-Vearrier/df8f91d2821f25fb5f504decdfa9fd9f84f32e7f
European rating of drug harms. (UK/ Netherlands) (abst – 2015) https://www.ncbi.nlm.nih.gov/pubmed/25922421
A safer alternative: Cannabis substitution as harm reduction. (USA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25919477
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study. (Italy) (abst – 2015) https://www.semanticscholar.org/paper/Efficacy-and-safety-of-nabiximols-(Sativex%C2%AE)-on-in-Ferr%C3%A8-Nuara/3de44eca12cb1f92457e31f6cb0f794056b13763
Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization. (USA) (abst – 2015) https://www.semanticscholar.org/paper/Medical-Cannabis-in-Arizona%3A-Patient-Perceptions%2C-Troutt-DiDonato/ea8edf5cd9955049c9e4a9112821c53102142998 Cannabinoids for pediatric epilepsy? Up in smoke or real science? (USA) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers. (UK) (full – 2016) http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience. (Israel) (full – 2016) http://www.seizure-journal.com/article/S1059
-1311(16)00005-4/fulltext Is the medical use of cannabis a therapeutic option for children? (Canada) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Associations Between Cannabis Use and Physical Health Problems in Early Midlife. (USA/ New Zealand/ UK) (full – 2016) http://archpsyc.jamanetwork.com/article.aspx?articleid=2526003
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? (Switzerland) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes. (USA) (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines. (Canada) (full – 2016) https://www.ncbi.nlm.nih.gov/books/NBK395789/
Medical cannabis use in Canada: vapourization and modes of delivery. (Canada) (full – 2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and Interest Prior to Program Launch. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083080/
top

Change in perceived risk associated with marijuana use in the United States from 2002 to 2012. (USA) (abst – 2015) https://www.semanticscholar.org/paper/Change-in-perceived-risk-associated-with-marijuana-Okaneku-Vearrier/df8f91d2821f25fb5f504decdfa9fd9f84f32e7f
European rating of drug harms. (UK/ Netherlands) (abst – 2015) https://www.ncbi.nlm.nih.gov/pubmed/25922421
A safer alternative: Cannabis substitution as harm reduction. (USA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25919477
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study. (Italy) (abst – 2015) https://www.semanticscholar.org/paper/Efficacy-and-safety-of-nabiximols-(Sativex%C2%AE)-on-in-Ferr%C3%A8-Nuara/3de44eca12cb1f92457e31f6cb0f794056b13763
Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization. (USA) (abst – 2015) https://www.semanticscholar.org/paper/Medical-Cannabis-in-Arizona%3A-Patient-Perceptions%2C-Troutt-DiDonato/ea8edf5cd9955049c9e4a9112821c53102142998 Cannabinoids for pediatric epilepsy? Up in smoke or real science? (USA) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers. (UK) (full – 2016) http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience. (Israel) (full – 2016) http://www.seizure-journal.com/article/S1059-1311(16)00005-4/fulltext
Is the medical use of cannabis a therapeutic option for children? (Canada) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Associations Between Cannabis Use and Physical Health Problems in Early Midlife. (USA/ New Zealand/ UK) (full – 2016) http://archpsyc.jamanetwork.com/article.aspx?articleid=2526003
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? (Switzerland) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes. (USA) (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines. (Canada) (full – 2016) https://www.ncbi.nlm.nih.gov/books/NBK395789/
Medical cannabis use in Canada: vapourization and modes of delivery. (Canada) (full – 2016) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and Interest Prior to Program Launch. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083080/
Cannabis – Position Paper of the German Respiratory Society (DGP). (Germany) (abst in English & German, link to PDF in German – 2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0042-100040
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies. (Germany) (abst in English & German – 2016) http://link.springer.com/article/10.1007%2Fs00482-015-0089-y
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. (Germany) (abst in English & German – 2016) https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana. (USA) (abst – 2016) http://www.tandfonline.com/doi/full/10.3109/00952990.2015.1135158
MEDICAL CANNABIS. (Israel) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
A review of the additive health risk of cannabis and tobacco co-use. (USA) (abst – 2016) https://www.sciencedirect.com/science/article/pii/S0376871616302101
Chapter 5 – Quality Control and Stability Assessment. (USA) (abst – 2016) http://www.sciencedirect.com/science/article/pii/B9780128046463000059
Plant-Derived and Endogenous Cannabinoids in Epilepsy. (Italy) (abst – 2016) https://link.springer.com/article/10.1007/s40261-016-0379-x
Cannabinoids: Medical implications. (USA) (abst – 2016) https://www.semanticscholar.org/paper/Cannabinoids%3A-Medical-implications.-Schrot-
Hubbard/2aab2c83e7a45a160550cdad7a2c877e02b2c9cc Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA. (UK) (abst – 2016) http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30071-2/abstract
Attitudes to legalizing cannabis use. (Australia/ Germany/ Netherlands/ USA) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27037958
Merck Manual – Marijuana (Cannabis) Consumer version. (USA) (full – 2017) http://www.merckmanuals.com/home/special-subjects/recreational-drugs-and-intoxicants/marijuana
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives. (USA/ UK) (full – 2017) http://meetinglibrary.asco.org/record/140727/edbook#fulltext
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. (Brazil/ Spain/ USA) (full – 2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/
Cannabinoids in Pediatrics. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy? (Republic of Korea) (full – 2017) http://www.j-epilepsy.org/journal/view.php?year=2017&vol=7&page=16
top
Cannabis Users’ Recommended Warnings for Packages of Legally Sold Cannabis: An Australia-Centered Study. (Spain) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531364/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. (Germany) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569620/
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy. (Mexico) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368357/
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges. (Hungary) (full – 2017) https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full
Vaping medical marijuana. (USA) (full – 2017) http://www.tandfonline.com/doi/full/10.1080/00325481.2018.1413281
Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview. (Italy) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738750/
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? (Italy) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767492/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
The Use of Medical Cannabis with Other Medications: A Review of Safety and Guidelines [Internet]. (Canada) (full – 2017) https://www.ncbi.nlm.nih.gov/books/NBK470766/
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana. (USA) (full – 2017) http://pediatrics.aappublications.org/content/139/4/e20162675.long
Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725759/
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta- analysis. (Canada) (full – 2017) https://journals.lww.com/anesthesia-analgesia/Fulltext/2017/11000/Selective_Cannabinoids_for_Chronic_Neuropathic.32.aspx
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among young adults in Colorado: Implications for health education and research. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593776/
Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis. (Switzerland/ France/ UK) (full – 2017) https://onlinelibrary.wiley.com/doi/full/10.1111/bju.13759
Developmental effects of cannabidiol and Δ9-tetrahydrocannabinol in zebrafish. (USA) (full – 2017) https://academic.oup.com/toxsci/article/162/1/137/4585009
Occurrence of illicit drugs in water and wastewater, and their removal during wastewater treatment. (Australia) (link to PDF – 2017) https://www.researchgate.net/publication/318712489_Occurrence_of_illicit_drugs_in_water_and_wastewater_and_their_removal_during_wastewater_treatment
Efficacy of Medical Cannabis for Treatment of Refractory Epilepsy in Children and Adolescents with Emphasis on the Israeli Experience. (Israel) (link to PDF – 2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4041
Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination. (Italy) (link to PDF – 2017) https://www.researchgate.net/publication/315799787_Short-Term_Efficacy_of_CBD-Enriched_Hemp_Oil_in_Girls_with_Dysautonomic_Syndrome_after_Human_Papillomavirus_Vaccination
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications. (Israel) (link to PDF – 2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
Pharmacological Foundations of Cannabis Chemovars. (USA/ Czech Republic) (link to PDF – 2017) https://www.researchgate.net/publication/321223960_Pharmacological_Foundations_of_Cannabis_Chemovars
Pregnant Women’s Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm (USA) (link to PDF–2017) https://www.researchgate.net/publication/314197610_Pregnant_Women’s_Current_and_Intended_Cannabis_Use_in_Relation_to_Their_Views_Toward_Legalization_and_Knowledge_of_Potential_Harm
Benefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A Systematic Review. (USA) (link to PDF – 2017) https://www.hsrd.research.va.gov/publications/esp/cannabis.cfm
Can we make cannabis safer? (UK) (download – 2017) https://discovery.ucl.ac.uk/id/eprint/1543247/1/Freeman_Can%20we%20make%20cannabis%20safer2_clean.pdf
The current status of artisanal cannabis for the treatment of epilepsy in the United States. (USA) (link to download – 2017) The current status of artisanal cannabis for the treatment of epilepsy in the United States Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management – An overview of systematic reviews. (Germany/ Canada) (click “researchgate” for download – 2017) https://scholar.google.com/scholar?cluster=14327516406392679206&hl=en&as_sdt=0,5&as_vis=1
Cannabis Intoxication Case Series: The Dangers of Edibles Containing Tetrahydrocannabinol (USA) (click “alternate sources”, then “isiarticles” for download–2017) https://www.semanticscholar.org/paper/Cannabis-Intoxication-Case-Series%3A-The-Dangers-of-Vo-Horng/6854e0c5d9aa7588d0ffafe42a515fca0ca57278
A 10-year review of cannabis exposure in children under 3-years of age: do we need a more global approach? (France) (abst – 2017) https://link.springer.com/article/10.1007%2Fs00431-017-2872-5
Pharmacologic Implications of Marijuana Use During Pregnancy. (USA) (abst – 2017) https://nwhjournal.org/article/S1751-4851(17)30097-1/fulltext
Carbonyl Compounds Produced by Vaporizing Cannabis Oil Thinning Agents (USA) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28355118
Marijuana Use in the Elderly: Implications and Considerations. (USA) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28595684
A little “dab” will do ya’ in: a case report of neuro-and cardiotoxicity following use of cannabis concentrates. (USA) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28644052
Is there a role for cannabidiol in psychiatry? (Brazil/ France) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28112021
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials. (Brazil/ Canada) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0965229917304466
Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation. (Italy) (abst – 2017) https://www.msard-j
ournal.com/article/S2211-0348(17)30148-7/fulltext Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: Absence of adverse effects in female Swiss mice. (Brazil) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0273230017304014
Efficacy and safety of cannabis for treating children with refractory epilepsy. (UK) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Cannabis for the treatment of Crohn’s disease. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517156/
(abst + summary in English & Spanish – 2018) https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012853.pub2/full
Merck Manual – Marijuana (Cannabis) Professional version. (USA) (full – 2018) http://www.merckmanuals.com/professional/special-subjects/recreational-drugs-and-intoxicants/marijuana-cannabis
Contemporary Routes of Cannabis Consumption: A Primer for Clinicians. (USA) (full – 2018) http://jaoa.org/article.aspx?articleid=2671435
Urgent need for federal investment in research on cannabis health impacts, say researchers. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798990/
Toxicity, Cannabinoids. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/books/NBK482175/
New York Physicians’ Perspectives and Knowledge of the State Medical Marijuana Program. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899285/
An Assessment of the Genotoxicity and Subchronic Toxicity of a Supercritical Fluid Extract of the Aerial Parts of Hemp. (USA/ Hungary) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011091/
Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective. (Israel) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999798/

top
A Cross-Sectional Study of Cannabidiol Users. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043845/
Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057224/
Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for chronic pain. (Israel/ UK) (full – 2018) https://www.dovepress.com/personal-experience-and-attitudes-of-pain-medicine-specialists-in-isra-peer-reviewed-fulltext-article-JPR
Adverse Effects of Cannabis on Male Reproduction. (USA) (full – 2018) https://www.eu-focus.europeanurology.com/article/S2405-4569(18)30225-6/fulltext
Elucidating the Impact of Adolescent Marijuana Use. (USA) (full – 2018) https://www.jahonline.org/article/S1054-139X(18)30238-6/fulltext
Therapeutic Use of medicinal cannabis in difficult to manage epilepsy. (Australia) (full – 2018) https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bcp.13711
Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis. (Brazil) (full – 2018) https://www.frontiersin.org/articles/10.3389/fneur.2018.00759/full
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. (Brazil) (full – 2018) https://www.frontiersin.org/articles/10.3389/fimmu.2018.02009/full
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. (Canada) (full – 2018) https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-fulltext-article-
DHPS Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial. (Canada/ USA) (full – 2018) https://www.epilepsybehavior.com/article/S1525-5050(18)30483-9/fulltext
Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer. (Australia) (full – 2018) http://www.clinicaltherapeutics.com/article/S0149-2918(17)31114-1/fulltext
Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC. (USA) (full – 2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.01084/full
Does perception of drug-related harm change with age? A cross-sectional online survey of young and older people. (UK) (full – 2018) https://bmjopen.bmj.com/content/8/11/e021109.long
Examining the Association between the Body Burdens of Harmful Chemicals and the Heaviness of Marijuana Smoking. (USA) (full – 2018) https://pubs.acs.org/doi/10.1021/acs.chemrestox.8b00160
Efficacy of cannabinoids in paediatric epilepsy. (New Zealand/ Australia) (full – 2018) https://onlinelibrary.wiley.com/doi/full/10.1111/dmcn.14087
Epilepsy and Cannabis: A Literature Review. (Pakistan/ USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235654/
Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence. (Australia/ UK) (full – 2018) https://jnnp.bmj.com/content/89/7/741.long
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome. (USA/ UK/ Spain) (full – 2018) https://www.nejm.org/doi/full/10.1056/NEJMoa1714631
Cannabis in palliative care: current challenges and practical recommendations. (Canada/ USA) (full – 2018) http://apm.amegroups.com/article/view/20097/21242
Erratum to cannabis in palliative care: current challenges and practical recommendations. (Canada/ USA) (erratum – 2018) http://apm.amegroups.com/article/view/23880/23545
Perceptions of plain packaging and health warning labels for cannabis among young adults: findings from an experimental study. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288865/
Cannabis for peripheral neuropathy: The good, the bad, and the unknown. (USA) (full – 2018) https://www.ccjm.org/content/85/12/943.long
Cannabinoids and Pain: New Insights From Old Molecules. (Serbia) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277878/
Weighing the Benefits and Risks of Medical Marijuana Use: A Brief Review. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306710/
The Misclassification of Medical Marijuana. (USA) (full – 2018) http://jaapl.org/content/46/4/472.long
Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157909/
Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878137/
Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476562/
Perceptions of the Comparative Safety of Different Forms of Marijuana Use Among the Adult US Population. (USA) (full – 2018) https://link.springer.com/article/10.1007%2Fs11606-018-4741-y
A Reciprocal Effects Analysis of Cannabis Use and Perceptions of Risk. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938114/
Practical considerations in medical cannabis administration and dosing. (Canada/ Czech Republic) (link to PDF – 2018) https://www.researchgate.net/publication/322257368_Practical_considerations_in_medical_cannabis_administration_and_dosing
Medical Cannabis for Older Patients. (Canada/ Germany) (link to PDF – 2018) https://www.researchgate.net/publication/329275718_Medical_Cannabis_for_Older_Patients
Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems—A Retrospective Feasibility Study. (Israel) (link to PDF – 2018) tikunolamusa.com Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders. (Israel) (link to PDF – 2018) https://www.researchgate.net/publication/325179753_Medical_Cannabis_for_Pediatric_Moderate_to_Severe_Complex_Motor_Disorders
Occupational health and safety in cannabis production: an Australian perspective (Australia) (link to PDF–2018) https://www.researchgate.net/publication/328067710_Occupational_health_and_safety_in_cannabis_production_an_Australian_perspective
Cannabis for the Treatment of Epilepsy: an Update. (USA) (link to PDF – 2018) https://www.researchgate.net/publication/324263327_Cannabis_for_the_treatment_of_paediatric_epilepsy_An_update_for_Canadian_paediatricians
Cannabis and Anti-Cancer Drugs: Societal Usage and Expected Pharmacological Interactions – A Review. (France) (download – 2018) http://www.ch-thuir.fr/sites/default/files/Bouqui-_et_al-2018-Fundamental_%26_Clinical_Pharmacology.pdf
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. (Israel) (click “researchgate” for download – 2018) https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5
Monoacylglycerol Lipase Inhibitor is Safe when Combined with Delayed r-tPA Administration in Treatment of Stroke. (Iran) (click “rumsacir” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Monoacylglycerol+Lipase+Inhibitor+is+Safe+when+Combined+with+Delayed+r-tPA+Administration+in+Treatment+of+Stroke.&btnG
Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats. (USA) (click “mybestbudca” for download – 2018) https://scholar.google.com/scholar?q=%22Toxicology+of+Marijuana,+Synthetic+Cannabinoids,+and+Cannabidiol+in+Dogs+and+Cats%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
What really happened after Colorado legalized marijuana? (USA) (editorial – 2018) http://www.cmaj.ca/content/190/41/E1237.long
Peering Through the Haze of Smoked vs Vaporized Cannabis—To Vape or Not to Vape? (Australia) (article – 2018) https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2716984
Safety of cannabidiol prescribed for children with refractory epilepsy. (Italy) (letter – 2018) https://www.mja.com.au/journal/2018/209/5/safety-cannabidiol-prescribed-children-refractory-epilepsy
Medical Cannabis and AASM Position Statement: The Don’t Ask, Don’t Tell Wishing Well. (USA) (letter – 2018) http://jcsm.aasm.org/ViewAbstract.aspx?pid=31418
Stop the Attack on Minnesota’s Courageous Stance to Allow Its Residents to Sleep Safely. (USA) (letter – 2018) http://jcsm.aasm.org/ViewAbstract.aspx?pid=31419
Medical Cannabis, Synthetic Marijuana Extracts, and Obstructive Sleep Apnea. (USA) (letter – 2018) http://jcsm.aasm.org/ViewAbstract.aspx?pid=31420
Intoxication From Accidental Marijuana Ingestion in Pediatric Patients: What May Lie Ahead. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29406477
Medical Cannabis: The Oncology Nurse’s Role in Patient Education About the Effects of Marijuana on Cancer Palliation. (USA) (abst – 2018) https://cjon.ons.org/cjon/22/1/medical-cannabis-oncology-nurse-s-role-patient-education-about-effects-marijuana-cancer
An overview of health and safety in the Colorado cannabis industry. (USA) (abst – 2018) https://www.semanticscholar.org/paper/An-overview-of-health-and-safety-in-the-Colorado-Walters-Fisher/015e56388768b1f1fd3ea7b0cf11ea2a9739365e
Medical cannabis: aligning use to evidence‐based medicine approach. (Israel) (abst – 2018) https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bcp.13657
Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an ‘index’ for monitoring and evaluation. (Canada/ Brazil/ Germany) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29860521
Investigational cannabinoids in seizure disorders, what have we learned thus far? (Serbia) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29842819
Cannabinoids for Treatment of MS Symptoms: State of the Evidence. (USA) (abst – 2018) https://link.springer.com/article/10.1007%2Fs11910-018-0859-x
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention. (Germany/ Australia) (abst – 2018) https://link.springer.com/article/10.1007%2Fs40263-018-0539-z
https://www.semanticscholar.org/paper/Role-of-the-Endocannabinoid-System-in-the-of-for-Leweke-Mueller/fe7f478e85a4f0fa37d1389d5ead3b2df83455d7
Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review. (Canada) (abst – 2018) https://taomc.org/en/evidence-base/safety-and-efficacy-of-nabilone-for-acute-chemotherapy-induced-vomiting-prophylaxis-in-pediatric-patients-a-multicenter-retrospective-review
Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut Syndrome: A Systematic Review and Meta-Analysis. (Italy) (abst – 2018) https://link.springer.com/article/10.1007%2Fs40263-018-0558-9
https://www.semanticscholar.org/paper/Efficacy-and-Safety-of-Adjunctive-Cannabidiol-in-A-Lattanzi-Brigo/c4ea54cd471a6b7c849d581613b4abfb3c53dfd6
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta- Analysis. (Italy/ Austria/ Switzerland) (abst – 2018) https://link.springer.com/article/10.1007%2Fs40265-018-0992-5
https://www.semanticscholar.org/paper/Efficacy-and-Safety-of-Cannabidiol-in-Epilepsy%3A-A-Lattanzi-Brigo/c429239f478174ae12a2cffdd6521f662d8d7662
Medical cannabis use in older patients: Update on medical knowledge. (Canada) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0378512218306868
Marijuana use in transplantation: A call for clarity. (USA/ Canada) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30506888
2019 Cannabis and Cannabinoids (PDQ®) Patient Version. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK65875/
2019 Cannabis and Cannabinoids (PDQ®)Health Professional Version. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK65755/
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy. (Israel) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336869/
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence. (Poland) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406915/
Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review. (Canada/ USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369421/
An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine. (USA) (full – 2019) https://link.springer.com/article/10.1007%2Fs40122-019-0114-4
Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan). (Italy) (full – 2019) https://onlinelibrary.wiley.com/doi/full/10.1111/ijpp.12514
Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396837/
Review of the many faces of synthetic cannabinoid toxicities. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398358/
Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis. (Netherlands/ Sweden/ UK/ Spain) (full – 2019) https://link.springer.com/article/10.1007%2Fs00213-019-05238-8
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials. (Italy) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514832/
Medical Marijuana: What Physicians Need to Know. (USA) (full – 2019) https://www.psychiatrist.com/JCP/article/Pages/2019/v80/18ac12537.aspx
Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice. (Germany) (full – 2019) https://www.frontiersin.org/articles/10.3389/fnbeh.2019.00094/full
Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry. (Germany) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535492/
Safety and Efficacy of Medical Cannabis in Fibromyalgia. (Israel) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616435/
Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration. (USA) (full – 2019) https://www.mdpi.com/1420-3049/24/12/2256/htm
A systematic review of cannabidiol dosing in clinical populations. (UK/ USA) (full – 2019) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.14038
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. (USA) (full – 2019) https://www.mdpi.com/2077-0383/8/7/989/htm
The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study. (Israel) (full – 2019) https://www.epilepsybehavior.com/article/S1525-5050(19)30305-1/fulltext
Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines [Internet]. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK546424/
Should more patients be offered treatment with cannabinoids? (Norway) (full – 2019) https://tidsskriftet.no/en/2019/09/kronikk/should-more-patients-be-offered-treatment-cannabinoids
American Epilepsy Society (AES): Written Comments to Norman E. “Ned” Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS): on Docket ID# FDA-2019-N- 1482, Scientific Data and Information about Products Containing Cannabis or Cannabis- Derived Compounds; Public Hearing; Request for Comments: Submitted on: July 16, 2019. (USA) (full – 2019) https://journals.sagepub.com/doi/full/10.1177/1535759719878716?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Are there mortality risks for patients with epilepsy who use cannabis treatments as monotherapy? (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S2213323218301567
Cannabis for musculoskeletal pain and arthritis: Evidence is needed. (France) (full – 2019) https://www.sciencedirect.com/science/article/pii/S1297319X18300472
Medical Cannabis for Older Patients-Treatment Protocol and Initial Results. (Israel) (full – 2019) https://www.mdpi.com/2077-0383/8/11/1819/htm
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. (Germany/ Tanzania) (full – 2019) https://link.springer.com/article/10.1007%2Fs00406-019-00984-4
Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use. (Brazil) (full – 2019) https://www.frontiersin.org/articles/10.3389/fneur.2019.01145/full
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids. (Australia) (full – 2019) https://www.mdpi.com/1422-0067/20/23/6079/htm
Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey. (USA/ Australia) (full – 2019) https://bmcfampract.biomedcentral.com/articles/10.1186/s12875-019-1059-8
A Warning against the Negligent Use of Cannabidiol in Professional and Amateur Athletes. (Germany) (full – 2019) https://www.mdpi.com/2075-4663/7/12/251/htm
Medical Cannabis Use in Palliative Care: Review of Clinical Effectiveness and Guidelines – An Update [Internet]. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK551867/
Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study. (USA) (full – 2019) https://annals.org/aim/fullarticle/2729208/acute-illness-associated-cannabis-use-route-exposure-observational-study
Emergency Department Visits From Edible Versus Inhalable Cannabis. (USA) (full – 2019) https://www.researchgate.net/publication/333039450_Emergency_Department_Visits_From_Edible_Versus_Inhalable_Cannabis
Perceptual Styles and Cannabis Consumption Prediction in Young People (Spain) (full–2019) https://www.mdpi.com/1660-4601/17/1/288/htm
Health considerations of the legalization of cannabis edibles. (Canada) (full – 2019) https://www.cmaj.ca/content/192/1/E1
.long In vitro antileishmanial and antioxidant potential, cytotoxicity evaluation and phytochemical analysis of extracts from selected medicinally important plants. (Pakistan/ Brazil) (link to PDF – 2019) https://www.researchgate.net/publication/332128770_In_vitro_antileishmanial_and_antioxidant_potential_cytotoxicity_evaluation_and_phytochemical_analysis_of_extracts_from_selected_medicinally_important_plants
An overview of the adverse effects of cannabis use for Canadian physicians. (Canada) (link to PDF – 2019) https://www.researchgate.net/publication/336139287_An_overview_of_the_adverse_effects_of_cannabis_use_for_Canadian_physicians
Positive and Negative Effects of Cannabis and Cannabinoids on Health. (Israel) (link to PDF – 2019) https://www.researchgate.net/publication/331647567_Positive_and_Negative_Effects_of_Cannabis_and_Cannabinoids_on_Health
Should Oncologists Recommend Cannabis? (USA) (article – 2019) https://link.springer.com/article/10.1007%2Fs11864-019-0659-9
Cannabis-based treatments as an alternative remedy for epilepsy. (USA) (article – 2019) https://www.sciencedirect.com/science/article/pii/S221342201930157X
Cancer, Cannabis, and the Search for Relief. (USA) (article – 2019) https://jnccn.org/view/journals/jnccn/17/9/article-p1142.xml
Efficacy and safety of medicinal cannabis: results of the CaPRis study. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02965-3
Women’s perspectives about cannabis use during pregnancy and the postpartum period: An integrative review. (Canada) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0091743518303773
Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30616356
Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol. (Australia/ New Zealand) (abst – 2019) https://pubs.acs.org/doi/10.1021/acschemneuro.8b00651
Cannabinoid toxicity in pediatrics. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30694824
A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety. (USA) (abst – 2019) https://link.springer.com/article/10.1007%2Fs11912-019-0757-7

https://www.semanticscholar.org/paper/A-Comprehensive-Review-of-Cannabis-in-Patients-with-Steele-Arneson/9b14714b38fb30948ac061b426384b4b97630251
Marijuana risk perceptions are associated with past-month marijuana use among Black first-year college students at a historically Black university. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30714497
The Australian drug harms ranking study. (Australia/ UK) (abst – 2019) https://journals.sagepub.com/doi/abs/10.1177/0269881119841569
A Review of Human Studies Assessing Cannabidiol’s (CBD) Therapeutic Actions and Potential. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30730563
Impact of Medical Cannabis on Patient-Reported Symptoms for Patients With Cancer Enrolled in Minnesota’s Medical Cannabis Program. (USA) (abst – 2019) https://ascopubs.org/doi/abs/10.1200/JOP.18.00562?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=jop
Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30910443
A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0163725819300750
Illegal cannabis use is common among Danes with multiple sclerosis. (Denmark) (abst – 2019) https://www.msard-journal.com/article/S2211
-0348(19)30212-3/fulltext Cannabis-based medicines for chronic pain management: current and future prospects. (Israel/ UK) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31356363
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy. (Italy) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31372958
Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study. (USA) (abst – 2019) https://academic.oup.com/painmedicine/advance-article-abstract/doi/10.1093/pm/pnz153/5545189?redirectedFrom=fulltext
Medical marijuana use for pediatric oncology patients: single institution experience. (Israel) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31424297
Perception of Benefits and Harms of Medical Cannabis among Seriously Ill Patients in an Outpatient Palliative Care Practice. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31539298
Cannabinoids Identification in Lung Tissues of Young Cannabis Smokers Operated for Primary Spontaneous Pneumothorax and Correlation with Pathologic Findings. (Italy) (abst – 2019) https://www.karger.com/Article/Abstract/503456
Adverse events following Cannabis for medical use in Tuscany: an analysis of the Italian Phytovigilance database. (Italy) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31656045
Medicinal Cannabis: Issues of evidence. (Australia) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1876382019300216
Trends in marijuana edible consumption and perceptions of harm in a cohort of young adults. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0376871619304375?via%3Dihub
Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0887899418311688
Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment- resistant epilepsy: Systematic review and meta-analysis. (Brazil) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31731110
Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. (USA/ Italy) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1474442219300328
Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland. (Switzerland) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0376871619305034?via%3Dihub
Can CBD Reduce the Use of Pain Medication? Lessons from a Survey in a Pain Clinic Environment. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1526590019306522
A perspective on cannabinoids for treating epilepsy: do they really change the landscape? (UK) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0028390819304277?via%3Dihub
Sociopolitical Externalities Impacting Worker Health in Washington State’s Cannabis Industry. (USA) (abst – 2019) https://academic.oup.com/annweh/advance-article-abstract/doi/10.1093/annweh/wxz083/5648905?redirectedFrom=fulltext
Rapid increase in the prevalence of cannabis use among persons with depression in the U.S., 2005-2017: the role of differentially changing risk perceptions. (USA) (abst – 2019) https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14883
Medical Cannabis Users’ Comparisons between Medical Cannabis and Mainstream Medicine. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30616501
Cannabis and Pain Treatment-A Review of the Clinical Utility and a Practical Approach in Light of Uncertainty. (Israel/ Canada) (download – 2020) Cannabis and Pain Treatment—A Review of the Clinical Utility … Medical Cannabis in Children. (Israel) (link to download – 2020) Medical Cannabis in Children. Medical cannabis: Risks related to its indication prior to approval. (Argentina) (click “Full text links” for download – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31984702
Oncologists’ perspectives on medical marijuana use by older adults. (USA) (abst – 2020) https://www.geriatriconcology.net/article/S1879-4068(19)30413-8/fulltext


SAFETY AS A SUBSTANCE–NATURAL CANNABIS–ADVERSE REACTIONS
Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions. (USA) (full – 2018) http://www.mdpi.com/2305-6320/5/3/75/htm
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. (USA) (full – 2019) https://www.mdpi.com/2077-0383/8/7/989/htm
A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0163725819300750
Aversiveness and Meaningfulness of Uncomfortable Experiences with Edible Cannabis. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31352867
Unknown Tetrahydrocannabinol Edible Ingestion Resulting in Acute Stroke Presentation. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31982199
Cannabis and Pain Treatment-A Review of the Clinical Utility and a Practical Approach in Light of Uncertainty. (Israel/ Canada) (download – 2020) https://www.rmmj.org.il/userimages/1002/2/PublishFiles/1035Article.pdf
Medical Cannabis for Intractable Epilepsy in Childhood: A Review. (Israel) (link to download – 2020) https://www.rmmj.org.il/userimages/1024/1/PublishFiles/1029Article.pdf
Development of Raynaud Phenomenon Following Use of Medical Cannabis. (Israel) st (1 page – 2020) https://journals.lww.com/jclinrheum/Citation/publishahead/Development_of_Raynaud_Phenomenon_Following_Use_of.98787.aspx
Abrupt withdrawal of cannabidiol (CBD): A randomized trial. (UK/USA) (abst – 2020) https://www.epilepsybehavior.com/article/S1525-5050(19)31116-3/fulltext


SAFETY AS A SUBSTANCE–SYNTHETICS
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal. (USA) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923337/
What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials. (India) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020770/
Developmental and reproductive toxicity studies of BIA 10-2474. (USA/ Switzerland) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0273230019303071?via%3Dihub
Oral repeated-dose toxicity studies of BIA 10–2474 in Wistar rat. (USA/ Switzerland) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0273230019303046?via%3Dihub

Oral repeated-dose toxicity studies of BIA 10–2474 in CD-1 mice. (USA/ Switzerland) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0273230019303216?via%3Dihub
Oral repeated-dose toxicity studies of BIA 10-2474 in cynomolgus monkeys. (Switzerland/ USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0273230019303113?via%3Dihub
Oral repeated-dose toxicity studies of BIA 10-2474 in beagle dogs. (USA/ Switzerland) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0273230019303198?via%3Dihub
Nabilone. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK547865/
Dronabinol. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK548830/
Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis. (Poland/ Germany) (full – 2019) https://www.jgld.ro/jgld/index.php/jgld/article/view/265/167
Perfusion Index Analysis in Patients Presenting to the Emergency Department Due to Synthetic Cannabinoid Use. (Turkey) (link to PDF – 20 19) https://www.mdpi.com/1010-660X/55/12/752
Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats. (USA/ Italy) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31579946
The cannabidiol conundrum potential benefits and risks of cannabidiol products for children. (USA) (abst – 2019) https://journals.lww.com/co-pediatrics/Abstract/publishahead/The_cannabidiol_conundrum__potential_benefits_and.98783.aspx
Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy. (Romania) (full – 2020) https://www.mdpi.com/1010-660X/56/1/24/htm
A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents. (India) (abst – 2020) https://www.sciencedirect.com/science/article/pii/S0223523419311055


SAFETY-ADULTERANTS/CONTAMINANTS*+
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia. (Ethiopia) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Cannabis microbiome sequencing reveals several mycotoxic fungi native to dispensary grade Cannabis flowers. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897766/
Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. (USA) (link to PDF – 2015) https://www.jstage.jst.go.jp/article/jts/40/6/40_797/_article
False hashish without cannabis resin. (Israel/ Czech Republic) (link to PDF – 2015) https://www.researchgate.net/publication/281229311_False_hashish_without_cannabis_resin
Eagle 20 and Myclobutanil in the Context of Cannabis cultivation and Consumption. (USA) (article – 2015) http://www.coloradogreenlab.com/blog/eagle-20-and-myclobutanil-in-the-context-of-cannabis-cultivation-and-consumption
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of st Butane Hash Oil. (USA) (1 page – 2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan. (Pakistan) (abst – 2015) https://www.semanticscholar.org/paper/Phytoaccumulation-of-Heavy-Metals-in-Natural-at-the-Irshad-Ruqia/b4ff9e3274f2f42059ab81c8765a6305c06935c2
Determination of herbicides paraquat, glyphosate, and aminomethylphosphonic acid in marijuana samples by capillary electrophoresis. (Brazil) (abst – 2015) https://www.ncbi.nlm.nih.gov/pubmed/25413634
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis. (Netherlands) (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00108/full
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? (Switzerland) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes. (USA) (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (USA) (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089129/
Analysis of a commerical marijuana e-cigarette formulation. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867395/
Alveolar haemorrhage following a cannabis water pipe. (Tunisia) (abst in English & French – 2016) http://www.em-consulte.com/article/1084024/alertePM
Acute intoxication of four individuals following use of the synthetic cannabinoid MAB- CHMINACA. (Poland) (abst – 2016) https://www.semanticscholar.org/paper/Acute-intoxication-of-four-individuals-following-of-Adamowicz-
Giero%C5%84/0f007aff43e55616ca2e88d7502ce9882c45a202 High Time to Assess the Environmental Impacts of Cannabis Cultivation. (UK/ USA) (full – 2017) http://pubs.acs.org/doi/full/10.1021/acs.est.6b06343
Identification of a Widespread Palmitoylethanolamide Contamination in Standard Laboratory Glassware. (USA/ Italy) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510777/
Expert Panel on Understanding Cannabis: Medicine, Society, Government. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657088/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
Marijuana “bong” pseudomonas lung infection: a detrimental recreational experience. (Malaysia) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756717/
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among young adults in Colorado: Implications for health education and research. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593776/
Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences. (USA/ Australia) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363769/
Endogenous synthesis of pyrethrins by cannabis. (Not all strains, just “Medihaze”, so far.- GSC) (USA) (link to PDF – 2017) http://www.biorxiv.org/content/early/2017/07/28/169417
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA. (Australia) (link to PDF – 2017) https://www.researchgate.net/publication/312491240_Acute_and_residual_effects_in_adolescent_rats_resulting_from_exposure_to_the_novel_synthetic_cannabinoids_AB-PINACA_and_AB-FUBINACA
How four U.S. states are regulating recreational marijuana edibles (USA) (link to PDF–2017) https://www.researchgate.net/publication/315611236_How_four_US_states_are_regulating_recreational_marijuana_edibles
The use of pesticides in Belgian illicit indoor cannabis plantations. (Belgium/ Czech Republic) (click “coreacuk” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+use+of+pesticides+in+Belgian+illicit+indoor+cannabis+plantations.&btnG Pesticide Use on Cannabis. (USA) (link to article – 2017) https://www.technologynetworks.com/tn/white-papers/pesticide-use-on-cannabis-288143
Into the void: Regulating pesticide use in Colorado’s commercial cannabis markets. (Australia) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28173984
Disseminated aspergillosis in an HIV-positive cannabis user taking steroid treatment (UK) (abst–2017) http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30438-3/fulltext
Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations. (Italy) (full – 2018) http://www.mdpi.com/1420-3049/23/5/1230/htm
Notes from the Field: Acute Poisonings from a Synthetic Cannabinoid Sold as Cannabidiol — Utah, 2017–2018. (USA) (full – 2018) https://www.cdc.gov/mmwr/volumes/67/wr/mm6720a5.htm?s_cid=mm6720a5_w
Hepatitis A virus infection associated with cannabis use. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764743/
Butane hash oil and dabbing: insights into use, amateur production techniques, and potential harm mitigation. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220730/
The Spice of Life…and Death: A Case Presentation and Review of Synthetic Marijuana Use in Mississippi. (USA) (full – pages 16-17 – 2018) https://issuu.com/jmsmamanagingeditor/docs/september_2016_jmsma_final_1.13.17
Cannabis Contaminants – sources, distribution, human toxicity and pharmacologic effects. (Australia) (full – 2018) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.13695
Microbial hazards during harvesting and processing at an outdoor United States cannabis farm. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314012/
Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878137/
Cryptococcal meningitis in a daily cannabis smoker without evidence of immunodeficiency. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787011/
Infectious risks associated with medicinal Cannabis: Potential implications for immunocompromised patients? (USA) (link to PDF – 2018) https://www.researchgate.net/publication/322990000_Infectious_risks_associated_with_medicinal_Cannabis_Potential_implications_f
or_immunocompromised_patients Healthy and Concentrated Cannabis Plants: How to Use Acronyms to Optimize Production. (USA) (link to download – 2018) https://www.ingentaconnect.com/content/aoac/jaoac/pre-prints/content-jaoac_180205;jsessionid=18xjnorbe71aw.x
-ic-live-02# Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries (Australia/Denmark/UK/Belgium) (click “ugentbe” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Growing+practices+and+the+use+of+potentially+harmful+chemical+additives+among+a+sample+of+small-scale+cannabis+growers+in+three+countries&btnG
How Close to the “Honeypot?” A Comparative Analysis of Cannabis Markets Under Two Different Policies Toward Personal Cultivation. (Czech Republic/ Australia) (abst – 2018) http://journals.sagepub.com/doi/full/10.1177/1057567717744857
Multiresidue Method of Analysis of Pesticides in Medical Cannabis. (Canada) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29843862
Implementation of a generic SFC-MS method for the quality control of potentially counterfeited medicinal cannabis with synthetic cannabinoids. (Belgium) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S1570023218302034?via%3Dihub
Brodifacoum-contaminated synthetic marijuana: clinical and radiologic manifestations of a public health outbreak causing life-threatening coagulopathy. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30022308
Lung injury from inhaling butane hash oil mimics pneumonia. (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S2213007118303769?via%3Dihub
Pulmonary mucormycosis associated with medical marijuana use. (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S221300711830282X
Review of the many faces of synthetic cannabinoid toxicities. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398358/
Into the Weeds: Regulating Pesticides in Cannabis. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785225/
Emerging Public Health Law and Policy Issues Concerning State Medical Cannabis Programs. (USA) (full – 2019) https://journals.sagepub.com/doi/full/10.1177/1073110519857331?url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed Cannabis Contaminants: Regulating Solvents, Microbes, and Metals in Legal Weed. (USA) (full – 2019) https://ehp.niehs.nih.gov/doi/full/10.1289/EHP5785
Pesticides and trace elements in cannabis: Analytical and environmental challenges and opportunities. (Canada) (full – 2019) https://www.sciencedirect.com/science/article/pii/S1001074219309696
Outbreak of Electronic-Cigarette-Associated Acute Lipoid Pneumonia – North Carolina, July-August 2019. (USA) (full – 2019) https://www.cdc.gov/mmwr/volumes/68/wr/mm6836e1.htm?s_cid=mm6836e1_w
Severe Pulmonary Disease Associated with Electronic-Cigarette–Product Use — Interim Guidance. (USA) (full – 2019) https://www.cdc.gov/mmwr/volumes/68/wr/mm6836e2.htm?s_cid=mm6836e2_w
Notes from the Field: Environmental Contamination from E-cigarette, Cigarette, Cigar, and Cannabis Products at 12 High Schools – San Francisco Bay Area, 2018-2019. (USA/ Netherlands) (full – 2019) https://www.cdc.gov/mmwr/volumes/68/wr/mm6840a4.htm?s_cid=mm6840a4_w
Characteristics of a Multistate Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping – United States, 2019. (USA) (full – 2019) https://www.cdc.gov/mmwr/volumes/68/wr/mm6839e1.htm?s_cid=mm6839e1_w
Pathogens and Molds Affecting Production and Quality of Cannabis sativa L.. (Canada) (full – 2019) https://www.frontiersin.org/articles/10.3389/fpls.2019.01120/full
A Warning against the Negligent Use of Cannabidiol in Professional and Amateur Athletes. (Germany) (full – 2019) https://www.mdpi.com/2075-4663/7/12/251/htm
Cannabis Contaminants: Regulating Solvents, Microbes, and Metals in Legal Weed. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791536/
Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues (USA) (link to PDF–2019) https://www.researchgate.net/publication/330504784_Adverse_outcome_pathway_of_developmental_neurotoxicity_resulting_from_prenatal_exposures_to_cannabis_contaminated_with_organophosphate_pesticide_residues
Standard Method Performance Requirements (SMPRs®) 2018.011: Identification and Quantitation of Selected Pesticide Residues in Dried Cannabis Materials. (not given) (link to download – 2019) https://www.aoac.org/wp-content/uploads/2020/01/SMPR2018_011.pdf

Why medical cannabis is still out of patients’ reach-an essay by David Nutt. (UK) (click “drugscience” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Why+medical+cannabis+is+still+out+of+patients%27+reach-an+essay+by+David+Nutt.&btnG
A sensitive multiresidue method for the determination of pesticides in marijuana by liquid chromatography–tandem mass spectrometry. (Brazil) (click “helsinkifi” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=A+sensitive+multiresidue+method+for+the+determination+of+pesticides+in+marijuana+by+liquid+chromatography%E2%80%93tandem+mass+spectrometry&btnG
The professionalization of cannabis growing. (Canada) (article – 2019) https://www.nature.com/articles/d41586-019-02527-2
A Review of Human Studies Assessing Cannabidiol’s (CBD) Therapeutic Actions and Potential. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30730563
High-potency cannabis and incident psychosis: correcting the causal assumption. (3) (USA) (abst– 2019) https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30178-6/fulltext
Cannabis resin in the region of Madrid: Adulteration and contamination. (Spain) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0379073819300751
Potential occupational and respiratory hazards in a Minnesota cannabis cultivation and processing facility. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31332812
Automated image analysis with ImageJ of yeast colony forming units from cannabis flowers. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0167701219305949
Comprehensive Determination of Unregulated Pesticide Residues in Oregon Cannabis Flower by LC-MS/MS and GC-MS/MS. (USA) (abst – 2019) https://pubs.acs.org/doi/10.1021/acs.jafc.9b01559
Cigarette Smokers vs. Co-users of Cannabis and Cigarettes: Exposure to Toxicants. (USA) (abst – 2019) https://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntz199/5588200?redirectedFrom=fulltext
Evaluation of Pesticides Found in Oregon Cannabis from 2016 to 2017. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31621879
Pesticide analysis in cannabis products. (Canada) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0021967319310787
Cannabis resin in the region of Madrid: Adulteration and contamination. (Spain) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0379073819300751
Pesticide analysis in cannabis products. (Canada) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0021967319310787?via%3Dihub
Hemorrhagic Soft Tissue Upper Airway Obstruction From Brodifacoum-Contaminated Synthetic Cannabinoid. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0736467919301337
Pesticides in cannabis: A review of analytical and toxicological considerations. (UK) (abst – 2019) https://onlinelibrary.wiley.com/doi/abs/10.1002/dta.2747
Analysis of Cannabinoid-Containing Fluids in Illicit Vaping Cartridges Recovered from Pulmonary Injury Patients: Identification of Vitamin E Acetate as a Major Diluent. (USA) (full – 2020) https://www.mdpi.com/2305-6304/8/1/8/htm
Cannabis, One Health, and Veterinary Medicine: Cannabinoids’ Role in Public Health, Food Safety, and Translational Medicine. (Israel/ Netherlands) (link to download – 2020) Cannabis, One Health, and Veterinary Medicine: Cannabinoids’ Role in Public Health, Food Safety, and Translational Medicine. Macro- and microelement content and health risk assessment of heavy metals in various herbs of Iran. (Iran) (abst – 2020) https://link.springer.com/article/10.1007%2Fs11356-020-07789-2


SALIVARY GLANDS/SALIVA
Saliva of obese patients – is it different? (Poland) (download – 2015) Saliva of obese patients–is it different? Disposable screen printed sensor for the electrochemical detection of delta-9- tetrahydrocannabinol in undiluted saliva. (UK) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722664/
The presence and distribution of cannabinoid type 1 and 2 receptors in the mandibular gland: The influence of different physical forms of diets on their expression in piglets. (Italy/ Germany) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/29218862
Immunohistochemical localization of cannabinoid receptor 1 (CB1) in the submandibular gland of mice under normal conditions and when stimulated by isoproterenol or carbachol. (Thailand/ Japan) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0003996917301474
Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid food: implications in fat taste, appetite and food liking. (Italy) (abst – 2018) http://pubs.rsc.org/en/Content/ArticleLanding/2018/FO/C7FO01772C#!divAbstract
https://www.semanticscholar.org/paper/Salivary-concentration-of-N-acylethanolamines-upon-Kong-Ferracane/9077ead3cdb629f664a8566d9ffde8b1f6af2169
Cannabinoids for Treatment of Dystonia in Huntington’s Disease (Germany/Austria) (abst-2018) https://www.ncbi.nlm.nih.gov/pubmed/29562549
Biological underpinnings from psychosocial stress towards appetite and obesity during youth: research implications towards metagenomics, epigenomics and metabolomics. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31298176
Salivary endocannabinoids as mediators in the relationship between omega-6 and omega- 3 fatty acid ratio intake from highly-processed foods and anthropometric markers of health in women. (Germany/ Spain) (abst – 2019) https://www.tandfonline.com/doi/abs/10.1080/09637486.2019.1632274?journalCode=iijf20


SCHISTOSOMA INFECTION+
Immunoregulatory Role of Cannabinoids during Infectious Disease. (Mexico) (full – 2017) https://www.karger.com/Article/FullText/481824
Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model. (Egypt) (full – 2019) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762019000100338&lng=en&nrm=iso&tlng=en


SCHIZOPHRENIA/MENTAL DISORDERS*+
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy. (USA) (case report – undated) http://www.cannabisclinicians.org/view/case-reports-directory/?gv_search=Cluster+A+%26+B+Personality+Disorders+&filter_31=&mode=any
An Introduction to the Endogenous Cannabinoid System. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789136/
Impact of Cannabis Use on the Development of Psychotic Disorders. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352721/
Synthetic cannabis-induced mania. (Turkey) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369931/
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice. (Brazil/ Italy) (full – 2015) http://ijnp.oxfordjournals.org/content/18/5/pyu041.long
Cannabis and psychopathology: The meandering journey of the last decade. (India) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462782/
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. (USA/ Canada) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640353/
A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches. (France) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676097/
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586320/
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. (UK/ Italy/ Netherlands/ Peru/ USA/ Germany) (full – 2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640936/
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia. (Spain) (full – 2015) http://neuro.psychiatryonline.org/doi/full/10.1176/appi.neuropsych.12120398
Further human evidence for striatal dopamine release induced by administration of Δ9- tetrahydrocannabinol (THC): selectivity to limbic striatum. (UK/ Netherlands) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816196/
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample. (USA/ Canada) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537180/
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior. (Germany/ France/ USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604232/
The phytocannabinoid, Δ(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects. (Italy/ UK) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337703/
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling . (USA/ Japan) (full – 2015) http://www.cell.com/cell/fulltext/S0092-8674(15)00826-0
Molecular Targets of Cannabidiol in Neurological Disorders. (UK) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604182/
Reduced Brain Cannabinoid Receptor Availability In Schizophrenia. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884543/
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762710/
Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis. (USA/ Canada) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037441/
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol. (Brazil/ Spain) (full – 2015) https://www.academia.edu/23675986/Decreased_glial_reactivity_could_be_involved_in_the_antipsychotic-like_effect_of_cannabidiol
Catatonia and Cannabis Withdrawal: a case report. (France) (link to PDF – 2015) https://www.researchgate.net/publication/280870215_Catatonia_and_Cannabis_Withdrawal_a_case_report
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences. (UK) (link to PDF– 2015) https://www.researchgate.net/publication/282873424_Genetic_moderation_of_the_effects_of_cannabis_Catechol-O-methyltransferase_COMT_affects_the_impact_of_D9- tetrahydrocannabinol_THC_on_working_memory_performance_but_not_on_the_occurrence_of_psychotic_e Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine. (Brazil) (link to PDF – 2015) https://www.researchgate.net/publication/276207070_Cannabidiol_effects_in_the_prepulse_inhibition_disruption_induced_by_amphetamine
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (Netherlands) (link to PDF – 2015) https://www.researchgate.net/publication/270966118_The_adverse_health_effects_of_synthetic_cannabinoids_with_emphasis_on_psychosis-like_effects
Endocannabinoids and Neurodegenerative Disorders: Parkinson’s Disease, Huntington’s Chorea, Alzheimer’s Disease, and Others. (Spain) (download – 2015)
Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis. (Brazil) (download – 2015) Cannabidiol and Sodium Nitroprusside: Two Novel … – Semantic Scholar A systematic review of the antipsychotic properties of cannabidiol in humans. (UK/ Netherlands) (click “academia” for download – 2015) https://scholar.google.com/scholar?q=A+systematic+review+of+the+antipsychotic+properties+of+cannabidiol+in+humans.&hl=en&as_sdt=0&as_vis=1&oi=scholart
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders. (Ireland) (click “academia” for download – 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=For+whom+the+endocannabinoid+tolls%3A+Modulation+of+innate+immune+function+and+implications+for+psychiatric+disorders.&btnG
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut. (USA) (article – 2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science. (USA) (interview – 2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lester-grinspoon/
Endocannabinoids and Mental Disorders. (Italy) (partial preview – 2015) https://books.google.com/books?hl=en&lr=&id=QwihCgAAQBAJ&oi=fnd&pg=PA260&ots=FMJszxDVrw&sig=am4Ix9Tha8igC52J71rUp_ZscFA#v=onepage&q&f=false
Association of single nucleotide polymorphisms in catechol-O-methyltransferase and serine-threonine protein kinase genes in the Pakistani schizophrenic population: a study with special emphasis on cannabis and smokeless tobacco. (Pakistan) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25801838
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms. (Spain/ UK) (abst – 2015) http://www.psyn-journal.com/article/S0925-4927(15)00112-2/fulltext
No additive effect of cannabis on cognition in schizophrenia. (Australia) (abst – 2015) https://www.semanticscholar.org/paper/No-additive-effect-of-cannabis-on-cognition-in-Power-Dragovi%C4%87/2ff162ed2d92f0b26b84f8971e3860d9e32e831f
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids. (UK) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26370602
The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway. (Sweden) (abst – 2015) https://www.sciencedirect.com/science/article/abs/pii/S0306452215009197
Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus. (USA) (abst – 2015) https://www.semanticscholar.org/paper/Deletion-of-CB2-cannabinoid-receptors-reduces-and-Li-Kim/4fdc30794391b95bd6375f0e9ab9e8b56110e99d
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience. (Canada) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory. (USA) (full – 2016) http://www.hindawi.com/journals/np/2016/9817089/
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers. (UK) (full – 2016) http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice. (Australia) (full – 2016) https://peerj.com/articles/2081/
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction. (Spain) (full – 2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=10095&path%5B
%5D=31745 First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone. (USA) (full – 2016) http://www.hindawi.com/journals/crips/2016/7257489/
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. (Israel/ Brazil) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158779
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial. (Spain) (full – 2016) http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1507-x

top
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History. (Spain) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160949
Endocannabinoid signaling in social functioning: an RDoC perspective. (USA) (full – 2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. (Brazil) (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00303/full
Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature. (USA) (full – 2016) https://www.hindawi.com/journals/crips/2016/3640549/
Assessing causality in associations between cannabis use and schizophrenia risk: a two- sample Mendelian randomization study. (UK) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341491/
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. (UK) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway. (Canada) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854973/
Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients. (Turkey) (full – 2016) https://www.dovepress.com/clinical-characteristics-of-synthetic-cannabinoid-induced-psychosis-in-peer-reviewed-fulltext-article-
NDT Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release. (USA) (full – 2016) http://www.cell.com/neuron/fulltext/S0896-6273(16)30509-8
Salience attribution and its relationship to cannabis-induced psychotic symptoms. (UK) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122315/
Lipids in psychiatric disorders and preventive medicine. (Germany/ USA) (full – 2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use. (USA) (full – 2016) https://academic.oup.com/schizophreniabulletin/article-lookup/doi/10.1093/schbul/sbw030
Violence and self-harm in severe mental illness: inpatient study of associations with ethnicity, cannabis and alcohol. (Sri Lanka/ New Zealand) (full – 2016) http://journals.sagepub.com/doi/full/10.1177/1039856216671650
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatients’ Daily Lives. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056804/
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks. (Canada/ Australia/ USA/ Spain) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350061/
Pros and cons of medical cannabis use by people with chronic brain disorders. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652027/
Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007165/
Vascular Dysfunction in a Transgenic Model of Alzheimer’s Disease: Effects of CB1R and CB2R Cannabinoid Agonists. (Spain) (full – 2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00422/full
The effects of cannabis use on salience attribution: a systematic review. (UK) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489077/
Antipsychotic-like effects of M4 positive allosteric modulators are mediated by CB2 cannabinoid receptor-dependent inhibition of dopamine release. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033724/
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. (Australia/ USA/ India) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876729/
Could cannabidiol be used as an alternative to antipsychotics? (Canada) (link to PDF–2016) https://www.researchgate.net/publication/303674363_Could_cannabidiol_be_used_as_an_alternative_to_antipsychotics
Association of Anandamide with altered Binocular Depth Inversion Illusion in Schizophrenia. (Germany) (link to PDF – 2016) https://www.researchgate.net/publication/309138698_Association_of_Anandamide_with_altered_Binocular_Depth_Inversion_Illusion_in_Schizophrenia
Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients. (Israel) (link to PDF – 2016) https://www.researchgate.net/publication/316915954_Cannabis_and_Alcohol_Abuse_Among_First_Psychotic_Episode_Inpatients
Cannabis and Psychosis: a Critical Overview of the Relationship. (USA/ Switzerland) (link to PDF – 2016) https://www.researchgate.net/publication/291206031_Cannabis_and_Psychosis_a_Critical_Overview_of_the_Relationship
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders. (Iran) (link to PDF – 2016) https://www.researchgate.net/publication/291185238_The_endocannabinoid_system_and_NGF_are_involved_in_the_mechanism_of_action_of_resveratrol_A_multi-target_nutraceutical_with_therapeutic_potential_in_neuropsychiatric_disorders Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit. (China) (download – 2016) Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced … Abnormal white matter integrity in synthetic cannabinoid users. (Turkey/ Australia) (download – 2016) Abnormal white matter integrity in synthetic cannabinoid users Cannabidiol, neuroprotection and neuropsychiatric disorders. (Brazil) (link to download – 2016) Cannabidiol, neuroprotection and neuropsychiatric disorders
Keep off the grass? Cannabis, cognition and addiction. (UK/ USA) (click “READ THE FULL ARTICLE” for download – 2016) https://www.researchgate.net/publication/299975773_Keep_off_the_grass_Cannabis_cognition_and_addiction
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis. (USA) (click “researchgate” for download – 2016) https://scholar.google.com/scholar?q=Psychiatric+comorbidity+associated+with+synthetic+cannabinoid+use+compared+to+cannabis&hl=en&as_sdt=0&as_vis=1&oi=scholart
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia. (Australia) (click “uoweduau” for download – 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=A+systematic+review+of+the+effect+of+cannabidiol+on+cognitive+function%3A+Relevance+to+schizophrenia.++++&btnG
Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in Schizophrenia (Switzerland) (1st page–2016) http://www.biologicalpsychiatryjournal.com/article/S0006-3223%2816%2932303-4/abstract
Acute Psychosis after Consumption of Synthetic Cannabinoids. (Austria) (abst in German & English – 2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0042-103425
Drug Dependence and Toxicity of Law-Evading Drugs: Their Mechanisms Explored from Basic Research. (Japan) (abst in English – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27703102
(abst in Japanese – 2016) http://medicalfinder.jp/doi/abs/10.11477/mf.1416200568
Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study. (Israel) (abst – 2016) https://europepmc.org/article/med/27379411
Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report. (abst – 2016) (Turkey) https://www.ncbi.nlm.nih.gov/pubmed/27370060
A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder. (USA) (abst – 2016) http://link.springer.com/article/10.1007/s11126-016-9426-2/fulltext.html
https://www.semanticscholar.org/paper/A-Study-of-the-Impact-of-Cannabis-on-Doses-of-in-or-Babatope-Chotalia/93fee51228aaf396d753321e8717a7cd41fe5005
Does cannabidiol have a role in the treatment of schizophrenia? (Ireland/ Australia) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S0920996416302894
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis. (Spain) (abst – 2016) https://www.semanticscholar.org/paper/Dysregulated-peripheral-endocannabinoid-system-is-Bioque-Cabrera/b42ea635ace639c035ca942e437eaa36b0c4f967
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia. (Canada) (abst – 2016) https://link.springer.com/article/10.1007%2Fs12035-016-9697-5
https://www.semanticscholar.org/paper/Role-of-the-Endocannabinoid-System-in-the-of-
Fakhoury/7c838882b3b3de0c4b59d18544f0f33ef794a417 A Case of Butane Hash Oil (Marijuana Wax)-Induced Psychosis. (USA) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26820171
Cannabinoids for the Treatment of Schizophrenia: An Overview. (Italy) (abst – 2016) http://www.eurekaselect.com/139245/article
COMT Val158Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions. (Netherlands) (abst – 2016) https://www.semanticscholar.org/paper/COMT-Val158Met-genotype-and-cannabis-use-in-people-Nieman-Dragt/9ddaee9f859379d3f836c73ca651b80bf3e6a49d
Cannabis-induced psychosis associated with high potency “wax dabs”. (USA) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26876313
Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. (Italy) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26970364
Metabolic syndrome in people with a psychotic illness: is cannabis protective? (Australia) (abst – 2016) https://www.semanticscholar.org/paper/Metabolic-syndrome-in-people-with-a-psychotic-is-Waterreus-Prinzio/0c8797488e049a37df455ee78a54188e1fc2fb91 Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex. (Spain) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26987678
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. (Denmark/Norway) (abst – 2016) https://www.semanticscholar.org/paper/Gender-Differences-in-Associations-Between-Disorder-Ottosen-Petersen/bf7d54abe3b89507d1ab49d0bce06fe4f503badd
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults. (France) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S0306460316301678
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. (Brazil) (abst – 2016) https://www.semanticscholar.org/paper/Peripubertal-treatment-with-cannabidiol-prevents-of-Peres-Diana/b16a6a62a9bdcff79a0af1bbc81151334b14648f
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment. (USA) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S0306460316302477
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia. (Australia) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0278584616301269
Cannabis and a lower BMI in psychosis: What is the role of AKT1? (Netherlands/ Bangladesh) (abst – 2016) https://www.sciencedirect.com/science/article/pii/S0920996416303644\
Cannabinoids and Psychosis. (#3) (USA) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27568729
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia. (USA) (abst – 2016) https://www.sciencedirect.com/science/article/pii/S0165178116311878
https://www.semanticscholar.org/paper/Characterization-of-peripheral-cannabinoid-receptor-Chase-Feiner/11a2b3981d1decb8be83520b7b2d85e9948ffeb5
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia. (Hungary) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0304394016306930
Cannabinoids: Glutamatergic Transmission and Kynurenines. (Mexico) (abst – 2016) https://link.springer.com/chapter/10.1007/978-3-319-28383-8_10
The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay. (USA) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27710762
Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting. (USA) (abst – 2016) https://www.semanticscholar.org/paper/Characteristics-associated-with-synthetic-use-among-Joseph-Manseau/31bb1523704c1892afe1e7d16fff428dfc08c9ea
Targeting the Endocannabinoid System in Psychiatric Illness. (Canada) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27811555
The consequences of chronic cannabis smoking in vulnerable adolescents. (Australia) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S1526054216301245?via%3Dihub
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls. (Canada) (abst – 2016) https://www.brainstimjrnl.com/article/S1935-861X(16)30305-9/fulltext
https://www.semanticscholar.org/paper/Differential-effects-of-cannabis-dependence-on-in-Goodman-Bridgman/167a0f2193295e2a015a4f9c0f4889958998f998
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice. (Poland) (full – 2017) http://link.springer.com/article/10.1007%2Fs12640-017-9702-4
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders. (Brazil/ Spain/ USA) (full – 2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use. (Tunisia/ USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508788/
Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514308/
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid. (Israel) (full – 2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
New drugs in psychiatry: focus on new pharmacological targets. (Italy) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373420/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. (Germany) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members (USA) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569624/
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. (Brazil) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478733/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders. (Singapore) (full – 2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice. (France) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447368/
Schizophrenia and depression, two poles of endocannabinoid system deregulation. (Spain) (full – 2017) https://www.nature.com/articles/s41398-017-0029-y
Cannabinoid Modulation of the Stressed Hippocampus. (Brazil) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. (Canada) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698868/
Synthetic Pot: Not Your Grandfather’s Marijuana. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329767/
Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model. (Australia) (full – 2017) https://www.nature.com/articles/npp201740
Short communication: Genetic association between schizophrenia and cannabis use. (Netherlands/ USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753881/
THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell- Derived Neurons. (USA) (full – 2017) https://www.karger.com/Article/FullText/477762
A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus—A case report and review of the literature. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721953/
The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions. (Australia) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603813/
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia versus Non-Psychiatric Controls. (Canada) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603819/
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515287/
Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662001/
The risk of violence associated with novel psychoactive substance misuse in patients presenting to acute mental health services. (UK) (full – 2017) https://onlinelibrary.wiley.com/doi/full/10.1002/hup.2606
Mechanisms Underlying Sex Differences in Cannabis Use. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828236/
Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572754/
The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531192/
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids imbalance. (France) (full – 2017) https://www.jneurosci.org/content/37/29/6851.full
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments. (Canada) (click “PDF Reader” for full – 2017) https://kundoc.com/pdf-neuronal-and-molecular-effects-of-cannabidiol-on-the-mesolimbic-dopamine-system-.html
Death by self-mutilation after oral cannabis consumption. (France) (link to PDF – 2017) https://www.researchgate.net/publication/320801960_Death_by_self-mutilation_after_oral_cannabis_consumption
The effect of interactions between genetics and cannabis use on neurocognition. A review. (France) (link to PDF – 2017) https://www.researchgate.net/publication/321342559_The_effect_of_interactions_between_genetics_and_cannabis_use_on_neurocog
nition_A_review The impact of current cannabis use on general cognitive function in people with psychotic illness. (Australia) (link to PDF – 2017) https://academic.oup.com/schizophreniabulletin/article/43/suppl_1/S81/3075583
HDAC1 and HDAC3 Underlie Dynamic H3K9 Acetylation During Embryonic Neurogenesis and in Schizophrenia-like Animals. (Czech Republic/ Netherlands/ Austria/ Israel/ Italy) (link to PDF – 2017) https://www.researchgate.net/publication/315189959_HDAC1_and_HDAC3_Underlie_Dynamic_H3K9_Acetylation_During_Embry
onic_Neurogenesis_and_in_Schizophrenia-like_Animals Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? (France) (link to PDF – 2017) https://www.researchgate.net/publication/313599763_Heavy_cannabis_use_prior_psychosis_in_schizophrenia_clinical_cognitive_and_neurological_evidences_for_a_new_endophenotype
Synthetic Cannabinoids: psychopharmacology, clinical aspects, and psychotic onset. (Italy/ UK) (link to PDF – 2017) https://www.semanticscholar.org/paper/Synthetic-Cannabinoids%3A-Psychopharmacology%2C-Onset.-Martinotti-Santacroce/eaf68bab1fb1fffe2971635f0d3bc68c9309f2ac
Perspectives of cannabis use in the life experience of men with schizophrenia. (UK) (download – 2017)
Synthetic Cannabis Analogues and Suicidal Behavior: Case Report. (Portugal) (download – 2017) Synthetic Cannabis Analogues and Suicidal Behavior: Case Report Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis. (UK) (click “uclacuk” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Effect+of+continued+cannabis+use+on+medication+adherence+in+the+first+two+years+following+onset+of+psychosis&btnG
Understanding marijuana’s effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation. (USA) (click “researchgate” for download – 20 17) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Understanding+marijuana%27s+effects+on+functional+connectivity+of+the+default+mode+network+%09in+patients+with+schizophrenia+and+co- occurring+cannabis+use+disorder%3A+A+pilot+%09investigation.+++++++++++++&btnG Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial. (UK/ Poland/ Romania) (click “View PDF” for download–2017) https://www.semanticscholar.org/paper/Cannabidiol-(CBD)-as-an-Adjunctive-Therapy-in-A-Mcguire-Robson/3df3230aadf05436a16166dcabdc3ddd0ccd4ad6
Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study. (Germany) (click “researchgate” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Synthetic+Cannabinoid+Use+in+a+Psychiatric+Patient+Population%3A+A+Pilot+Study&btnG
Voluntary exercise improves cognitive deficits in female dominant-negative DISC1 transgenic mouse model of neuropsychiatric disorders. (Israel) (click “Alternate Sources” then “46cec243-71bb-” for download – 2017) https://www.semanticscholar.org/paper/Voluntary-exercise-improves-cognitive-deficits-in-Segal-Gavish-Barzilay/e9adb9bebe91894f3580738910184f418ad710f8
At the intersection of neurology and psychiatry : the impact of the differential diagnosis . (France) (abst in English & French – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28653514
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia (Italy/ Sweden/ Czech Republic/ USA) (abst – 2017) https://www.semanticscholar.org/paper/A-preliminary-study-of-endocannabinoid-system-in-of-D’Addario-Micale/3e4ae946739c4b62f3af43f9ee1ff07da7d295b5
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms. (Brazil/ Australia/ USA) (abst– 20 17) https://www.sciencedirect.com/science/article/abs/pii/S0022395616307373
Cannabis use, COMT, BDNF and age at first-episode psychosis. (Spain) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28142064
Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency Setting. (USA) (abst – 2017) http://www.tandfonline.com/doi/abs/10.1080/10826084.2016.1263663?journalCode=isum20
Associations between substance use disorders and suicide or suicide attempts in people with mental illness: A Danish nationwide, prospective, register-based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorder. (Denmark) (abst – 2017) https://onlinelibrary.wiley.com/doi/abs/10.1111/add.13788
Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats. (Italy) (abst – 2017) https://www.semanticscholar.org/paper/Metabolic-side-effects-induced-by-olanzapine-are-by-Lazzari-Serra/8a2e837c996b4c6ae703b5b96a6f212d51aee818
Cannabinoids as hippocampal network administrators. (USA) (abst – 2017) https://www.sciencedirect.com/science/article/abs/pii/S0028390817301405
https://www.semanticscholar.org/paper/Cannabinoids-as-hippocampal-network-administrators.-Lupica-Hu/949f5a77404edb21ceddb66df4d9777574370eff JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up. (Italy) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28441106
Synthetic cannabinoid use in an acute psychiatric inpatient unit. (Australia) (abst– 2017) https://www.ncbi.nlm.nih.gov/pubmed/28503792
Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet. (USA/ Greece) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0278584617302622?via%3Dihub
The association of cannabis use on inpatient psychiatric hospital outcomes. (USA) (abst – 2017) https://www.semanticscholar.org/paper/The-association-of-cannabis-use-on-inpatient-Rylander-Winston/e18de9e83905a26f6eaf8836b43b998eecfee160
Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. (USA) (abst – 2017) http://www.sciencedirect.com/science/article/pii/S0091305717301211
Characteristics of socially withdrawn youth in France: A retrospective study. (France) (abst – 2017) https://journals.sagepub.com/doi/abs/10.1177/0020764017704474?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=ispa
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles. (USA) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0306460317302721?via%3Dihub
https://www.semanticscholar.org/paper/DSM-5-cannabis-use-disorder-in-the-National-Survey-Kerridge-Pickering/c11711f19134a1b11d7aee2c3c64a10959b418e6
Is there a role for cannabidiol in psychiatry? (Brazil/ France) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28112021
Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology. (Canada) (abst – 2017) https://link.springer.com/article/10.1007%2Fs00213-017-4766-7
https://www.semanticscholar.org/paper/Phytocannabinoids-modulate-emotional-memory-through-Hudson-Rushlow/729a521847a1a948eb02fc324abca48487138579 Motivational changes of cannabis use prior to and during the course of schizophrenia. (Germany) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28004866
Cannabis induced psychosis and subsequent psychiatric disorders. (India) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S187620181730388X
Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. (Italy) (full in English & French – 2018) https://www.cambridge.org/core/journals/epidemiology-and-psychiatric-sciences/article/pharmacological-properties-of-cannabidiol-
in-the-treatment-of-psychiatric-disorders-a-critical-overview/D7FD68F40CF30CBB48A1025C66873F26/core-reader The reasons for use of cannabinoids and stimulants in patients with schizophrenia. (Poland) (links to full in English & Polish – 2018) http://psychiatriapolska.pl/261_273_S
From “Azalla” to Anandamide: Distilling the Therapeutic Potential of Cannabinoids. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752109/
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use. (Norway) (full – 2018) http://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)32024-2/fulltext
Prospective recovery of cannabis use in a psychotic population: A qualitative analysis. (Australia) (full – 2018) https://www.sciencedirect.com/science/article/pii/S2352853216300244
Dispensary cannabidiol marijuana and first-episode mania. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915243/
Detection of Significant Association Between Variants in Cannabinoid Receptor 1 Gene (CNR1) and Personality in African-American Population. (USA/ China) (full – 2018) https://www.frontiersin.org/articles/10.3389/fgene.2018.00199/full
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. (Canada) (full – 2018) https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-fulltext-article-
DHPS Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective. (Israel) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999798/
The Endocannabinoid System across Postnatal Development in Transmembrane Domain Neuregulin 1 Mutant Mice. (Australia) (full – 2018) https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00011/full
Substance Use and Psychological Disorders Among Art and Non-art University Students: an Empirical Self-Report Survey. (Hungary/ UK) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814514/
Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with Schizophrenia: An Ecological Cross-Sectional Study. (Italy) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037576/
Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users. (Australia) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908414/
Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007529/
The Endocannabinoid System, Aggression, and the Violence of Synthetic Cannabinoid Use, Borderline Personality Disorder, Antisocial Personality Disorder, and Other Psychiatric Disorders. (Canada) (full – 2018) https://www.frontiersin.org/articles/10.3389/fnbeh.2018.00041/full

The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences. (Canada/ UK) (full – 2018) https://bsd.biomedcentral.com/articles/10.1186/s13293-018-0182-x
Evidence for the use of “medical marijuana” in psychiatric and neurologic disorders. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007658/
Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders. (Germany/ Spain/ Italy) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969305/
Effects of Adolescent THC Exposure on the Prefrontal GABAergic System: Implications for Schizophrenia-Related Psychopathology. (Canada) (full – 2018) https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00281/full
Cannabis, a Significant Risk Factor for Violent Behavior in the Early Phase Psychosis. Two Patterns of Interaction of Factors Increase the Risk of Violent Behavior: Cannabis Use Disorder and Impulsivity; Cannabis Use Disorder, Lack of Insight and Treatment Adherence. (Switzerland/ UK) (full – 2018) https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00294/full
Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues. (UK/ Italy/ Greece) (full – 2018) http://www.mdpi.com/2076-3425/8/7/133/htm
The Role of Cannabis within an Emerging Perspective on Schizophrenia. (USA) (full – 2018) http://www.mdpi.com/2305-6320/5/3/86/htm
Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia. (Brazil) (full – 2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00901/full
Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia. (Netherlands) (full – 2018) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-018-0253-7
Lipidome alterations in human prefrontal cortex during development, aging, and cognitive disorders. (China/ Russia/ USA/ Germany) (full – 2018) https://www.nature.com/articles/s41380-018-0200-8
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders. (Italy/ USA) (full – 2018) https://www.mdpi.com/2305-6320/5/4/107/htm
Adolescent exposure to Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons. (USA) (full – 2018) https://www.nature.com/articles/s41380-018-0243-x
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. (Brazil) (full – 2018) https://www.frontiersin.org/articles/10.3389/fimmu.2018.02009/full
The impact of schizophrenia and intelligence on the relationship between age and brain volume. (Denmark/ Australia) (full – 2018) https://www.sciencedirect.com/science/article/pii/S2215001318300167?via%3Dihub
A successful microsurgical approach to treating penile amputation following genital self mutilation. (warning – graphic photos) (UK) (full – 2018) https://academic.oup.com/jscr/article/2018/10/rjy271/5126893
Associations between adolescent cannabis use and brain structure in psychosis. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959798/
Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States. (USA/ Curacau/ Russia) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200442/
Mental Health Issues and Substance Use in the United States: Pulling the Power Levers. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30406713
Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis. (Jamaica) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058192/
Important Questions About the Impact of Medical Marijuana on People With Serious Mental Illness. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436619/
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768049/
Adult cellular neuroadaptations induced by adolescent THC exposure in female rats are rescued by enhancing anandamide signaling. (Italy) (full – 2018) https://academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyy057/5047132
Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults A Systematic Review and Meta-analysis. (USA) (full – 2018) https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2678214
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex. (Italy) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837889/
The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety among Youth under 25 Years. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591882/
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203675/
Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: Data from the national RAISE-ETP study. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684200/
Impact of substance use disorder on gray matter volume in schizophrenia. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815746/
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. (Netherlands/ Australia/ USA/ UK/ Canada/ Estonia/ Spain/ Finland) (full– 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386176/
Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419500/
Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring. (Netherlands/ USA) (link to PDF – 2018) https://www.researchgate.net/publication/326224957_Maternal_and_paternal_cannabis_use_during_pregnancy_and_the_risk_of_psychotic-like_experiences_in_the_offspring Relationships between substance abuse/dependence and psychiatric disorders based on polygenic scores. (Spain) (link to PDF – 2018) https://www.semanticscholar.org/paper/Associations-between-Polygenic-Risk-for-Psychiatric-Carey-Agrawal/7efd0879f4a8da6a6043f52cdf2dcb1dbe4958b7
Trajectories of alcohol and marijuana use among primary versus secondary psychopathy variants within an adjudicated adolescent male sample. (USA) (link to PDF – 2018) https://www.researchgate.net/publication/326856425_Trajectories_of_Alcohol_and_Marijuana_Use_Among_Primary_Versus_Secondary_Psychopathy_Variants_Within_an_Adjudicated_Adolescent_Male_Sample
Age moderates the association between frequent cannabis use and negative schizotypy over time. (Australia) (link to PDF – 2018) https://www.researchgate.net/publication/326517484_Age_moderates_the_association_between_frequent_cannabis_use_and_negative_schizotypy_over_time
The endocannabinoid system in mental disorders: Evidence from human brain studies (Spain) (link to PDF – 2018) https://www.researchgate.net/publication/326451892_The_endocannabinoid_system_in_mental_disorders_Evidence_from_human_brain_studies
Affect and cannabis use in daily life: a review and recommendations for future research. (USA) (link to PDF – 2018) https://www.researchgate.net/publication/327038512_Affect_and_cannabis_use_in_daily_life_a_review_and_recommendations_for_future_research
Psychotic-like experiences with cannabis use predict cannabis cessation and desire to quit: a cannabis discontinuation hypothesis. (UK) (click “View PDF” for ” for download – 2018) https://www.semanticscholar.org/paper/Psychotic-like-experiences-with-cannabis-use-and-to-Sami-Notley/d9e5b6c5e35732827235728cac297abeca458f9e
Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute Δ9-tetrahydrocannabinol (D9-THC). (Australia/ USA) (click “researchgate” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Reduced+type+III+neuregulin+1+expression+does+not+modulate+the+behavioural+sensitivity+of+mice+to+acute+%CE%94+9+-tetrahydrocannabinol+%28D+9+-THC%29&btnG
Genetic vulnerability to schizophrenia is associated with cannabis use patterns during adolescence. (Netherlands/ Belgium) (click “uunl” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Genetic+vulnerability+to+schizophrenia+is+associated+with+cannabis+use+patterns+during+adolescence%22&btnG

Spicing it up – synthetic cannabinoid receptor agonists and psychosis – a systematic review. (UK) (click “kclacuk” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Spicing+it+up+-+synthetic+cannabinoid+receptor+agonists+and+psychosis+-+a+systematic+review.%09%22&btnG
Inhibition of return (IOR) in patients with schizophrenia and cannabis use. (Germany/ Switzerland) (click “Alternate Sources”, then “iranarzeir” for download – 2018) https://www.semanticscholar.org/paper/Inhibition-of-return-(IOR)-in-patients-with-and-use-Schnell-Heekeren/df3abd4efdf2bc8fdb4c61b567191f920148cf55
Cannabinoids: just like any other medication? (UK) (article – 2018) https://www.thelancet.com/journals/lancet/article/PIIS0140
-6736(18)31611-8/fulltext Impact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in Schizophrenia Patients. (Switzerland/ Germany) (link to 1st page – 2018) https://www.thieme-connect.com/DOI/DOI?10.1055/a-0573-9866
Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0165178117311101
Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids (Russia) (abst–2018) https://link.springer.com/article/10.1007%2Fs11055-019-00724-0 https://www.semanticscholar.org/paper/A-Differential-Approach-to-the-Treatment-of-Acute-Kekelidze-Klimenko/1fdae2e9c8599f08b6d809bacd823a5095dedecc
Cannabinoids and glial cells: possible mechanism to understand schizophrenia. (Brazil) (abst – 2018) https://www.semanticscholar.org/paper/Cannabinoids-and-glial-cells%3A-possible-mechanism-to-Almeida-Martins-de-Souza/def584a15611061b5dfb80190421e150e7a3b491
Sex differences in the cardiometabolic health of cannabis users with a psychotic illness. (Australia) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618305787?via%3Dihub
Impaired glucocorticoid-mediated HPA axis negative feedback induced by juvenile social isolation in male rats. (Italy) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0028390818300510
https://www.semanticscholar.org/paper/Impaired-glucocorticoid-mediated-HPA-axis-negative-Boero-Pisu/8a30b692e50039f4d12673979963599d23c6c3f6
Changes in dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. (Canada) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618300681
Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC. (UK) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29502548
Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders (South Africa/UK) (abst–2018) https://www.sciencedirect.com/science/article/abs/pii/S0920996418301282?via%3Dihub
Familial Abnormalities of Endocannabinoid Signaling in Schizophrenia (Germany/USA/Australia) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29521179
The relationship between the level of exposure to stress factors and cannabis in recent onset psychosis. (Spain) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29743139
Is cannabis a risk factor for suicide attempts in men and women with psychotic illness? (Australia) (abst – 2018) https://link.springer.com/article/10.1007%2Fs00213-018-4924-6
https://www.semanticscholar.org/paper/S103.-IS-CANNABIS-A-RISK-FACTOR-FOR-SUICIDE-IN-MEN-Waterreus-Prinzio/1f9181265a6131ed33f3219565f747db748a789e Childhood trauma- and cannabis-associated microstructural white matter changes in patients with psychotic disorder: a longitudinal family-based diffusion imaging study. (Netherlands) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29807550
Risk of criminal justice system involvement among people with co-occurring severe mental illness and substance use disorder. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29852999
Attention deficit hyperactivity disorder and arrest history: Differential association of clinical characteristics by sex. (Canada) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29853005
Cannabidiol effects on prepulse inhibition in nonhuman primates. (Brazil/ USA) (abst – 2018) https://www.semanticscholar.org/paper/Cannabidiol-effects-on-prepulse-inhibition-in-Saletti-Tomaz/b1451e17d0e857463bd81eef7e213bf5312904ee
Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto- striatal resting-state connectivity. (Germany) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0924977X18301135
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention. (Germany/ Australia) (abst – 2018) https://link.springer.com/article/10.1007%2Fs40263-018-0539-z
https://www.semanticscholar.org/paper/Role-of-the-Endocannabinoid-System-in-the-of-for-Leweke-Mueller/fe7f478e85a4f0fa37d1389d5ead3b2df83455d7
Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains. (Brazil) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30070429
The interaction between the ZNF804A gene and cannabis use on the risk of psychosis in a non-clinical sample. (Spain) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0278584618300988
Psychosis and synthetic cannabinoids. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0165178117314312?via%3Dihub
Differences in demographic and clinical characteristics between cannabis users and non- drug users: A retrospective study of patients at first hospitalization due to psychotic symptoms. (Israel) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0165178118304062
Poverty matters: Cannabis use among people with serious mental illness: Findings from the United States survey on drug use and health, 2015. (Italy/ UK) (abst – 2018) http://journals.sagepub.com/doi/abs/10.1177/0020764018795213

Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies. (Canada/ USA) (abst – 2018) https://www.nature.com/articles/s41401-018-0081-z
Genetic Predisposition vs Individual-Specific Processes in the Association Between Psychotic-like Experiences and Cannabis Use. (USA/ UK) (abst – 2018) https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2707243
Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors. (Canada) (abst – 2018) https://www.semanticscholar.org/paper/%CE%94-9-Tetrahydrocannabinol-and-Cannabidiol-produce-on-Szkudlarek-Desai/4d996f4ca45cfbb64253ea7f3a6566162e2c994b Attenuated psychotic experiences and cannabis use in adolescents in the general population. (Spain) (full in English, abst in Spanish – 2019) https://www.researchgate.net/publication/326977718_Attenuated_psychotic_experiences_and_cannabis_use_in_adolescents_in_the_general_population
Cannabidiol in Anxiety and Sleep: A Large Case Series. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/
Exploring associations between early substance use and longitudinal socio-occupational functioning in young people engaged in a mental health service. (Australia/ Qatar/ Germany) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336340/
Review of the many faces of synthetic cannabinoid toxicities. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398358/
Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9- Tetrahydrocannabinol Administration in Humans. (UK/ Belgium) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523579/
Cannabis and Psychosis: Are We any Closer to Understanding the Relationship? (UK) (full – 2019) https://link.springer.com/article/10.1007%2Fs11920-019-1044-x
Synthetic Cannabinoids-“Spice” Can Induce a Psychosis: A Brief Review. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450675/
The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review. (Netherlands) (full – 2019) https://www.mdpi.com/2077-0383/8/7/1058/htm
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation. (Italy) (full – 2019) https://www.frontiersin.org/articles/10.3389/fnbeh.2019.00202/full
Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748779/
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review. (Germany/ Tanzania) (full – 2019) https://link.springer.com/article/10.1007%2Fs00406-019-00984-4
Exploring the impact of adolescent exposure to cannabinoids and nicotine on psychiatric risk: insights from translational animal models. (Canada) (full – 2019) https://www.cambridge.org/core/journals/psychological-medicine/article/exploring-the-impact-of-adolescent-exposure-to-
cannabinoids-and-nicotine-on-psychiatric-risk-insights-from-translational-animal- models/B547AEB58CE93A3938419B65BC1968D9/core-reader Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice. (Poland) (full – 2019) https://link.springer.com/article/10.1007%2Fs12035-019-1596-0
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry. (Italy/ Greece) (full – 2019) https://www.hindawi.com/journals/ecam/2019/2509129/
The relationship between motivations for cannabis consumption and problematic use. (Spain) (links to PDF in English & Spanish – 2019) http://adicciones.es/index.php/adicciones/article/view/1221
Cannabis tourist destinations: Risk for vulnerable travellers with pre-existing mental disorders. (Israel) (link to PDF – 2019) https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taz098/5671717
An overview of the adverse effects of cannabis use for Canadian physicians. (Canada) (link to PDF – 2019) https://www.researchgate.net/publication/336139287_An_overview_of_the_adverse_effects_of_cannabis_use_for_Canadian_physicians
Life-long epigenetic programming of cortical architecture by maternal ‘Western’ diet during pregnancy (Austria/UK/Germany/France/Italy/Hungary/Japan/Canada/USA/Sweden) (link to PDF– 2019) https://www.researchgate.net/publication/337326915_Life-long_epigenetic_programming_of_cortical_architecture_by_maternal_’Western’_diet_during_pregnancy
Docosahexaenoic acid,22:6n-3: its roles in the structure and function of the brain. (India/ Finland/ Norway) (link to PDF – 2019) https://www.researchgate.net/publication/336635472_Docosahexaenoic_acid226n-3_Its_roles_in_the_structure_and_function_of_the_brain
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia. (Czech Republic/ Italy/ Germany/ Israel) (download – 2019) https://www.holistichempextracts.com/wp-content/uploads/2019/06/Peripubertal-cannabidiol-treatment-rescues-behavioral-and-neurochemical-abnormalities-in-the-MAM-model-of-schizophrenia.pdf
What are the psychological effects of using synthetic cannabinoids? A systematic review. (UK) (click “uclacuk” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22What+are+the+psychological+effects+of+using+synthetic+cannabinoids%3F+A+systematic+review.%22&btnG
Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis. (Croatia) (click “researchgate” for download – 2019) https://scholar.google.com/scholar?cluster=18275787695831253471&hl=en&as_sdt=0,5
Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia. (Spain/ UK) (click “sativaisticatedcom” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Endocannabinoid+system+imbalance+in+the+postmortem+prefrontal+cortex+of+subjects+with+schizophrenia.&btnG
Lost in translation: an overinterpretation of the acute effects of cannabinoids. (USA) (letter – 2019) https://www.nature.com/articles/s41398-019-0669-1
Synthetic cannabinoid use disorder: an update for general psychiatrists. (Australia) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30663326
Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study. (Spain) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30702972
A Review of Human Studies Assessing Cannabidiol’s (CBD) Therapeutic Actions and Potential. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30730563
High-potency cannabis and incident psychosis: correcting the causal assumption. (1) (USA) (abst– 2019) https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30130-0/fulltext
High-potency cannabis and incident psychosis: correcting the causal assumption. (2) (USA) (abst– 2019) https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30175-0/fulltext
High-potency cannabis and incident psychosis: correcting the causal assumption. (3) (USA) (abst– 2019) https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30178-6/fulltext
Cannabis use and violence in patients with severe mental illnesses: A meta-analytical investigation. (Canada) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0165178118323862
Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition. (Italy) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0278584618307206
Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors. (Brazil) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0278584618308340?via%3Dihub
The association between cannabis use and psychiatric comorbidity in people with personality disorders: A population-based longitudinal study. (Israel/ Canada/ Germany) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0165178119308662
Measuring Disturbance of the Endocannabinoid System in Psychosis: A Systematic Review and Meta-analysis. (UK/ Italy) (abst – 2019) https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2735110
Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients. (Spain) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0278584619301393
Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders. (Australia) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0889159119302806?via%3Dihub
Age of onset of substance use in patients with dual diagnosis and its association with clinical characteristics, risk behaviors, course, and outcome: A retrospective study. (India) (abst – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657549/
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia. (Australia) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S027858461930106X?via%3Dihub
Cannabidiol (CBD) use in psychiatric disorders: A systematic review. (UK/ Italy) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0161813X19300774?via%3Dihub
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids. (UK/ Italy/ Netherlands) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31422779
Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit. (Brazil) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0028390819301649?via%3Dihub
Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis. (Spain/ Italy) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0924977X19302366?via%3Dihub
Nutrition and immunology in mental health: Precision medicine and integrative approaches to address unmet clinical needs in psychiatric treatments. (UK/ Taiwan) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0889159119312322?via%3Dihub
Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments. (Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31675939
Cannabidiol as a potential treatment for psychosis. (UK) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31741731
No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder. (Denmark) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31813396
Psychotic Disorders in Patients Who Use Synthetic Cannabinoids. (Russia) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31821228
Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats. (Israel/ Poland) (abst – 2019) https://link.springer.com/article/10.1007%2Fs12035-019-01831-2
Cannabis and Neuropsychiatric Disorders: An Updated Review. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31867704
Psychiatrists cancel cannabis debate after no one would argue for criminalising users. st (UK) (1 paragraphs – 2019) https://www.bmj.com/content/364/bmj.l417.long
News Feature: Cannabis and the adolescent brain. (USA) (full – 2020) https://www.pnas.org/content/117/1/7.long
Determining factors for Cannabis use among Moroccans Schizophrenic Patients: A cross sectional study. (Morocco) (full – 2020) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941683/
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. (Australia/ UK) (full – 2020) https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-019-2409-8
Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions. (Hungary) (full – 2020) https://www.mdpi.com/1420-3049/24/20/3709/htm
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis. (UK/ Italy) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31994476


SCHWANNOMATOSIS
Including cannabinoids in the treatment of painful schwannomatosis (Italy-full–2018)
https://onlinelibrary.wiley.com/doi/full/10.1002/brb3.1011


SCIATICIC NERVE INJURY
Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice. (USA/ Netherlands) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955845/
Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative. (Brazil) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0028390818304830
Supplementation of Cannabis sativa L. leaf powder accelerates functional recovery and ameliorates haemoglobin level following an induced injury to sciatic nerve in mouse model. (Pakistan/ France/ China) (link to PDF – 2019) https://www.researchgate.net/publication/331927590_Supplementation_of_Cannabis_sativa_L_leaf_powder_accelerates_functional_recovery_and_ameliorates_haemoglobin_level_following_an_induced_injury_to_sciatic_nerve_in_mouse_model


SCLERODERMA/SYSTEMIC SCLEROSIS+
Pathogenesis of Systemic Sclerosis (USA-full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways. (Spain/ Italy) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757881/
Cannabinoids, inflammation, and fibrosis. (USA) (full – 2016) https://www.fasebj.org/doi/full/10.1096/fj.201600646R
Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis? (Italy) (link to PDF – 2016) http://www.ima.org.il/imaj/ViewArticle.aspx?aId=3850
Cannabinoids and autoimmune diseases: A systematic review. (Israel) (click “cedfoundation” for download – 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Cannabinoids+and+autoimmune+diseases%3A+A+systematic+review.%22&btnG
Medical Cannabis – another piece in the mosaic of autoimmunity? (Israel) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
Ajulemic acid: potential treatment for chronic inflammation. (USA) (full – 2018) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1002/prp2.394
Cannabinoids in dermatology: a scoping review. (USA) (full – 2018) https://escholarship.org/uc/item/7pn8c0sb
The Therapeutic Potential of Cannabinoids in Dermatology. (USA) (full – 20 18) http://www.skintherapyletter.com/dermatology/cannabinoids-potential/
VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways. (Spain/ USA) (full – 2018) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.14450
Cannabinoids for the treatment of rheumatic diseases – where do we stand? (Israel) (abst–2018) https://www.nature.com/articles/s41584-018-0025-5
https://www.semanticscholar.org/paper/Cannabinoids-for-the-treatment-of-rheumatic-%E2%80%94-where-Katz-Talmor-Katz/396ec0b6a979675d276cea25f17e850ff5d0542f EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis. (Spain/ USA/ Italy) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303174
https://www.semanticscholar.org/paper/EHP%E2%80%90101%2C-an-oral-formulation-of-the-cannabidiol-and-Garc%C3%ADa%E2%80%90Mart%C3%ADn- Garrido%E2%80%90Rodr%C3%ADguez/fede4211fa1e22acee61403112cf4794713810e0 The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. (Spain/ Italy/ USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303484
https://www.semanticscholar.org/paper/The-endocannabinoid-system-of-the-skin.-A-potential-R%C3%ADo-Mill%C3%A1n/ee3c98a6a53a85c6f4bbd71bab445769ae791e32 Nabilone administration in refractory chronic diarrhea: a case series. (Italy) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593541/
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System. (Hungary) (full – 2019) https://www.mdpi.com/1420-3049/24/5/918/htm
Cannabis sativa as a Potential Treatment for Systemic Sclerosis. (Israel/ Portugal) (link to PDF – 2019) https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2019&month=03&page=217
Cannabinoids in the treatment of rheumatic diseases: Pros and cons. (Italy/ Israel/ Germany/ Canada/) (link to PDF – 2019) https://www.researchgate.net/publication/336710270_Cannabinoids_in_the_treatment_of_rheumatic_diseases_Pros_and_cons
Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis. (Spain/ USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0006295219300772
https://www.semanticscholar.org/paper/Cannabinoid-derivatives-acting-as-dual-agonists-as-Garc%C3%ADa%E2%80%90Mart%C3%ADn-Garrido%E2%80%90Rodr%C3%ADguez/515e3927e2902ebf6eced2188762100a8f4058a5 Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. (Israel) (link to download – 2020) Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases

top


SEBACEOUS GLANDS+
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content. (Pakistan) (link to download – 2015) https://pdfs.semanticscholar.org/7793/d0aa53912090ff3735cdd6d2f5179ae6b5d4.pdf
Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment. (Hungary/ Germany/ UK) (click “unideb” for download – 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Differential+effectiveness+of+selected+non%E2%80%90psychotropic+phytocannabinoids+on+human+sebocyte+functions+implicates+their+introduction+in+dry%2Fseborrhoeic+skin+and+acne+tre atment%22&btnG
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (Hungary) (full – 2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext
Recent advances in the endocrinology of the sebaceous gland. (Hungary) (full – 2018) https://www.tandfonline.com/doi/full/10.1080/19381980.2017.1361576
The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes- induced inflammation and lipogenesis in sebocytes. (Republic of Korea) (full – 2018) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202933
Endocannabinoid tone regulates human sebocyte biology. (Hungary/ Switzerland/ Italy/ Germany) (full – 2018) https://www.jidonline.org/article/S0022-202X(18)30147-7/fulltext
Effects of atopic dermatitis and gender on sebum lipid mediator and fatty acid profiles. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800162/
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System. (Hungary) (full – 2019) https://www.mdpi.com/1420-3049/24/5/918/htm


SEBORRHEA
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (Hungary) (full – 2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext


SEPTIC SHOCK/SEPSIS*+
New horizons for newborn brain protection: enhancing endogenous neuroprotection. (UK) (full – 2015) http://fn.bmj.com/content/100/6/F541
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376457/
Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591006/
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation. (Canada) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26410875
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation. (Canada) (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Involvement of Central Endothelin ETA and Cannabinoid CB1 Receptors and Arginine Vasopressin Release in Sepsis Induced by Cecal Ligation and Puncture in Rats. (Brazil) (full – 2016) https://journals.lww.com/shockjournal/FullText/2016/09000/Involvement_of_Central_Endothelin_ETA_and.10.aspx
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia. (Australia) (click “uoweduau” for download – 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=A+systematic+review+of+the+effect+of+cannabidiol+on+cognitive+function%3A+Relevance+to+schizophrenia.++++&btnG
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage. (Switzerland/ USA) (full – 2017) https://www.nature.com/articles/s41598-017-09808-8
N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1 (USA) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544930/
Immunoregulatory Role of Cannabinoids during Infectious Disease. (Mexico) (full – 2017) https://www.karger.com/Article/FullText/481824
Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock. (Canada) (full – 2017) http://www.mdpi.com/2218-1989/7/4/55/htm
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges. (Hungary) (full – 2017) https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full
An endocannabinoid uptake inhibitor from black pepper exerts pronounced anti- inflammatory effects in mice. (Mexico/ Switzerland) (link to PDF– 2017) http://pubs.acs.org/doi/abs/10.1021/acs.jafc.7b02979
Cannabinoids in the Cardiovascular System. (UK/ Canada) (partial preview – 2017) https://books.google.com/books?id=djRHDgAAQBAJ&pg=PA329&lpg=PA329&dq=%22Chapter+Ten+-+Cannabinoids+in+the+Cardiovascular+System%22&source=bl&ots=QXJdVSt-WA&sig=ACfU3U0viRFFCYzWd9NIVLl99cfuXeQmiQ&hl=en&sa=X&ved=2ahUKEwjWner86dbmAhVXjp4KHYtDBCEQ6AEw AnoECAcQAQ#v=onepage&q=%22Chapter%20Ten%20- %20Cannabinoids%20in%20the%20Cardiovascular%20System%22&f=false Betacaryophyllene – A phytocannabinoid as potential therapeutic modality for human sepsis? (Mexico/ Canada) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0306987717308617
Cannabis Sativa Revisited—Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis. (Romania) (full – 2020) https://www.mdpi.com/2073-4409/9/2/307/htm


SEX-BASED DIFFERENCES +*
Sex-dependent vulnerability to Cannabis abuse in adolescence. (Italy) (full – 2015) http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00056/full
Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and N-Palmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis. (UK) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385619/
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. (UK) (full – 2015) http://cardiovascres.oxfordjournals.org/content/early/2015/06/30/cvr.cvv179.long
Effects of deleting cannabinoid receptor-2 on mechanical and material properties of cortical and trabecular bone. (USA/ UK/ Canada) (full – 2015) http://www.tandfonline.com/doi/full/10.1080/23311916.2014.1001015
Vilazodone for cannabis dependence: A randomized, controlled pilot trial. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937726/
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441859/
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361312/
The role of AMP-activated protein kinase (AMPK) in the androgenic potentiation of cannabinoid-induced changes in energy homeostasis. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360013/
Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532757/
Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9- tetrahydrocannabinol in adult rats. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430373/
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633378/
Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences. (USA/ Canada) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528005/
The impact of gonadal hormones on cannabinoid dependence. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696547/
Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747417/
Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767576/
Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats. (USA) (full – 2015) http://www.sciencedirect.com/science/article/pii/S0091305715300885
Assessing the efficacy of MOTI-4 for reducing the use of cannabis among youth in the Netherlands: a randomized controlled trial. (Netherlands) (full – 2015) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(15)00296-2/fulltext
Cannabis use history and characteristics of quit attempts: A comparison study of treatment-seeking and non-treatment-seeking cannabis users. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250402/
Structural Stigma and Sexual Orientation Disparities in Adolescent Drug Use. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395540/
Gender minority social stress in adolescence: disparities in adolescent bullying and substance use by gender identity. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201643/
Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex . (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582007/
Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724469/
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival. (Greece/ France) (link to PDF – 2015) https://www.researchgate.net/publication/282875145_Evaluation_of_cannabinoid_CB1_and_CB2_receptors_expression_in_mobile_tongue_squamous_cell_carcinoma_Associations_with_clinicopathological_parameters_and_patients’_survival
Sex differences in associations between cannabis craving and neural responses to cannabis cues: Implications for treatment. (USA) (link to PDF – 2015) https://www.researchgate.net/publication/280628784_Sex_Differences_in_Associations_Between_Cannabis_Craving_and_Neural_Responses_to_Cannabis_Cues_Implications_for_Treatment
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes. (Spain) (click “researchgate” for download – 2015) https://scholar.google.com/scholar?q=Long-term+consequences+of+perinatal+and+adolescent+cannabinoid+exposure+on+neural+and+psychological+processes&hl=en&as_sdt=0&as_vis=1&oi=scholart
The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age. (USA) (click “academia” for download – 2015) https://scholar.google.com/scholar?cluster=14269505460730600403&hl=en&as_sdt=0,5
Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers. (USA) (click “academia” for download – 2015) https://scholar.google.com/scholar?q=%22Effect+of+oral+THC+pretreatment+on+marijuana+cue-induced+responses+in+cannabis+dependent+volunteers%22&hl=en&as_sdt=0&as_vis= 1&oi=scholart
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study. (USA) (abst – 2015) https://www.semanticscholar.org/paper/Association-between-cannabis-use-and-the-risk-of-Thomas-Wallner/9e5d7262609e10c514dad0ce457e7521b8deb50c
Cigarette smoking may modify the association between cannabis use and adiposity in males. (Canada) (abst – 2015) https://www.ncbi.nlm.nih.gov/pubmed/26026899
Change in perceived risk associated with marijuana use in the United States from 2002 to 2012. (USA) (abst – 2015) https://www.semanticscholar.org/paper/Change-in-perceived-risk-associated-with-marijuana-Okaneku-Vearrier/df8f91d2821f25fb5f504decdfa9fd9f84f32e7f
Role of CB2 receptors in social and aggressive behavior in male mice (Spain) (abst–2015) http://link.springer.com/article/10.1007%2Fs00213-015-3939-5
https://www.semanticscholar.org/paper/Role-of-CB2-receptors-in-social-and-aggressive-in-Rodr%C3%ADguez-Arias-Navarrete/b1d3ca6ab52d26c251408f502bce87a008ea25ac Strain and sex differences in puberty onset and the effects of THC administration on weight gain and brain volumes. (Canada) (abst – 2015) http://www.sciencedirect.com/science/article/pii/S0306452215006387
Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats. (Slovakia/ Czech Republic) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26238495
Sexual identity and prevalence of alcohol and other drug use among Australians in the general population. (Australia) (abst – 2015) https://www.sciencedirect.com/science/article/abs/pii/S0955395915003473
CANNABIS: ALTERNATIVE REALITIES (CRA). (Columbia/ Argentina) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26650405
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis. (USA) (abst – 2015) https://www.sciencedirect.com/science/article/pii/S0376871615016464
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students. (USA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review. (Iran) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726806/
Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey. (Canada) (full – 2016) http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0746-4
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood. (Israel) (full – 2016) http://learnmem.cshlp.org/content/23/7/349.long
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats. (Spain) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035052/
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring. (Spain) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0
165432 Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor- Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators. (Spain) (full – 2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States. (USA/ Australia/ UK) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072356/
Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123602/
Age of Sexual Debut and Cannabis Use in the United States. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852689/
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418128/
Sex Differences in Cannabinoid-Regulated Biology: A Focus on Energy Homeostasis. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783283/
Sex-dependent effects of cannabis-induced analgesia. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037015/
Violence and self-harm in severe mental illness: inpatient study of associations with ethnicity, cannabis and alcohol. (Sri Lanka/ New Zealand) (full – 2016) http://journals.sagepub.com/doi/full/10.1177/1039856216671650
Fabp1 gene ablation inhibits high fat diet-induced increase in brain endocannabinoids. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225076/
Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884498/
Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305303/
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5184775/
Sex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576608/
Estradiol impacts the endocannabinoid system in female rats to influence behavioral and structural responses to cocaine. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028287/
Gonadal hormone modulation of ∆9-tetrahydrocannabinol-induced antinociception and metabolism in female versus male rats. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5195865/
Childhood weight status and timing of first substance use in an ethnically diverse sample. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898759/
The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321672/
Sex differences in hippocampal response to endocannabinoids after exposure to severe stress. (Israel) (link to PDF – 2016) https://www.researchgate.net/publication/296634554_Sex_differences_in_hippocampal_response_to_endocannabinoids_after_exposure_to_severe_stress
UPPS-P model impulsivity and marijuana use behaviors in adolescents: A meta-analysis. (USA) (link to PDF – 2016) https://www.researchgate.net/publication/308576610_UPPS-
P_Model_Impulsivity_and_Marijuana_Use_Behaviors_in_Adolescents_A_Meta-Analysis Prevalence and Correlates of Vaping Cannabis in a Sample of Young Adults (USA) (link to PDF–2016) https://www.researchgate.net/publication/308173388_Prevalence_and_Correlates_of_Vaping_Cannabis_in_a_Sample_of_Young_Adults
COMPREHENSIVE MEDICAL MARIJUANA PATIENT STUDY. (USA) (article- link to PDF of study – 2016) https://hellomd.com/blogs/articles/download-our-medical-marijuana-patient-study
Traffic accidentability and risky driving behavior in young people in New Caledonia. Results of study. (France) (abst in English & French – 2016) http://www.em-consulte.com/article/1063492/alertePM
Mechanical and material properties of cortical and trabecular bone from cannabinoid receptor-1-null (Cnr1-/-) mice. (UK) (link to download – 2016) abdn.ac.uk Sex differences in the subjective effects of oral Δ9-THC in cannabis users. (USA) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0091305716300077
https://www.semanticscholar.org/paper/Sex-differences-in-the-subjective-effects-of-oral-Fogel-Kelly/bbe67e02f7dea81815ebe8c4278caa089f6aa8b8
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal. (USA) (abst–2016) https://www.sciencedirect.com/science/article/pii/S0892036216300101?via%3Dihub
Got Munchies? Estimating the Relationship between Marijuana Use and Body Mass Index. (USA) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27572145
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. (Denmark/Norway) (abst – 2016) https://www.semanticscholar.org/paper/Gender-Differences-in-Associations-Between-Disorder-Ottosen-Petersen/bf7d54abe3b89507d1ab49d0bce06fe4f503badd
Simultaneous HPLC-APCI-MS/MS quantification of endogenous cannabinoids and glucocorticoids in hair. (China/ Zambia) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1570023216303786
https://www.semanticscholar.org/paper/Simultaneous-HPLC-APCI-MS%2FMS-quantification-of-and-Mwanza-Chen/1cdcbeb9ec5b4c9cee7faa15fca92fb715ade492
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats. (USA) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S0306452216304055
https://www.semanticscholar.org/paper/Sex-and-hormone-dependent-alterations-in-alcohol-Henricks-Berger/129f03d7c57b76982786e278b8fee80eddb100d2
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid. (Ireland) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1043661816308660
Determining Cannabis Use Status From a Photograph: An Assessment of the “Jay-dar” in Neuropsychologists. (USA) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27779445
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences. (Spain) (abst – 2016) https://www.sciencedirect.com/science/article/pii/S0091305716302465
https://www.semanticscholar.org/paper/Sex-dependent-influence-of-chronic-mild-stress-on-Marco-Ballesta/1e34338039655a4bd51f035b574d9eb28da58dc6
Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the endocannabinoid system in white and brown adipose tissue of weanling rat offspring. (Brazil) (full in English & French – 2017) https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/perinatal-maternal-highfat-diet-induces-early-obesity-and- sexspecific-alterations-of-the-endocannabinoid-system-in-white-and-brown-adipose-tissue-of-weanling-rat-offspring/6BA3A77DE45A1537E0BC182E83EF07F0/core-reader Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey. (Ireland) (full – 2017) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0129-7
Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences. (Canada) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372283/
Adolescent Female Cannabinoid Exposure Diminishes the Reward-Facilitating Effects of Δ9-Tetrahydrocannabinol and d-Amphetamine in the Adult Male Offspring. (Greece/ USA) (full – 2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00225/full
The cannabis withdrawal syndrome: current insights . (Germany) (full – 2017) https://www.dovepress.com/the-cannabis-withdrawal-syndrome-current-insights-peer-reviewed-fulltext-article-SAR
Using Attitudes, Age and Gender to Estimate an Adolescent’s Substance Use Risk. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417548/
Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272923/
Cannabis and cognitive functioning in multiple sclerosis: The role of gender . (Canada) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468765/
A GPR119 Signaling System in the Murine Eye Regulates Intraocular Pressure in a Sex- Dependent Manner. (USA/ Taiwan) (full – 2017) http://iovs.arvojournals.org/article.aspx?articleid=2631571
Medical use of cannabis in Switzerland: analysis of approved exceptional licences. (Switzerland/ South Africa) (full – 2017) https://smw.ch/article/doi/smw.2017.14463
Synthetic Cannabinoid Use Among High School Seniors. (Australia/ USA) (full – 2017) http://pediatrics.aappublications.org/content/early/2017/09/07/peds.2017-1330.long
A moderate diet restriction during pregnancy alters the levels of endocannabinoids and endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of rat offspring in a sex-specific manner. (Spain/ Germany) (full – 2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174307
Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol Consumption in Mice. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777574/
Recreational marijuana legalization and college student use: Early evidence. (USA) (full – 2017) https://www.sciencedirect.com/science/article/pii/S2352827317300125?via%3Dihub
Recurrent cannabis use among Norwegian students. (Norway) (full – 2017) http://journals.sagepub.com/doi/full/10.1177/1455072517743427
Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N- acetylcysteine treatment (ACCENT) study. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323358/
Recreational Marijuana Use and Acute Myocardial Infarction: Insights from Nationwide Inpatient Sample in the United States. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752226/
Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636049/
Cannabis increased the risk of primary spontaneous pneumothorax in tobacco smokers: a case–control study. (Denmark) (full – 20 17) https://academic.oup.com/ejcts/article/52/4/679/3866758
Early cannabis initiation and educational attainment: is the association causal? Data from the French TEMPO study. (France/ USA) (full – 2017) https://academic.oup.com/ije/article/46/5/1641/3830700
Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648025/
Demographic Characteristics, Components of Sexuality and Gender, and Minority Stress and Their Associations to Excessive Alcohol, Cannabis, and Illicit (Noncannabis) Drug Use Among a Large Sample of Transgender People in the United States. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516932/
Determinants of peripheral airway function in adults with and without asthma (Australia/New Zealand/Canada) (full–2017) https://onlinelibrary.wiley.com/doi/full/10.1111/resp.13045
Cannabis Use and Hypomania in Young People: A Prospective Analysis. (UK) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192498/
Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high fat diet. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665667/
Comparison of the discriminative stimulus and response rate effects of Δ9- tetrahydrocannabinol and synthetic cannabinoids in female and male rats. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309167/
Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499986/
Associations between childhood ADHD, gender, and adolescent alcohol and marijuana involvement: A causally informative design. (USA) (full – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Associations+between+childhood+ADHD%2C+gender%2C+and+adolescent+alcohol+and+marijuana+%09involvement%3A+A+causally+informative+design.++++%22&btnG
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective. (USA) (full – 2017) https://www.nature.com/articles/npp2017140
Mechanisms Underlying Sex Differences in Cannabis Use. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828236/
School, Friends, and Substance Use: Gender Differences on the Influence of Attitudes Toward School and Close Friend Networks on Cannabis Involvement. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788785/
Monoacylglycerol lipase inhibition alters social behavior in male and female rats after post-weaning social isolation. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034682/
CB1 and ethanol effects on glutamatergic transmission in the central amygdala of male and female msP and Wistar rats. (USA/ Italy) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745318/
EFFECT OF MATERNAL HIGH-FAT DIET ON KEY COMPONENTS OF THE PLACENTAL AND HEPATIC ENDOCANNABINOID SYSTEM. (USA) (full – 2017) https://www.physiology.org/doi/full/10.1152/ajpendo.00119.2017
Antinociceptive effects of JWH015 in female and male rats. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849479/
Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women. (Spain) (link to PDF – 2017) https://www.researchgate.net/publication/321313324_Increased_plasma_oleoylethanolamide_and_palmitoleoylethanolamide_levels_correlate_with_inflammatory_changes_in_alcohol_binge_drinkers_the_case_of_HMGB1_in_women_Biolipids_in_binge_drinkers
Daily-level associations between PTSD and cannabis use among young sexual minority women. (USA) (link to PDF – 2017) https://www.researchgate.net/publication/317424016_Daily-level_associations_between_PTSD_and_cannabis_use_among_young_sexual_minority_women
Trends in Lifetime Cannabis Use among Czech School-aged Children from 2002 to 2014. (Czech Republic / Slovakia ) (link to PDF – 2017) http://apps.szu.cz/svi/cejph/show_en.php?kat=archiv/2017-sup-09
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking in Young Adults. (Greece) (link to PDF – 2017) https://www.researchgate.net/publication/317577645_Associations_of_Bullying_and_Cyberbullying_With_Substance_Use_and_Sexual_Risk_Taking_in_Young_Adults Endocannabinoid concentrations in plasma during the finishing period are associated with feed efficiency and carcass composition of beef cattle. (USA) (link to PDF – 2017) https://www.researchgate.net/publication/320387912_Endocannabinoid_concentrations_in_plasma_during_the_finishing_period_are_associated_with_feed_efficiency_and_carcass_composition_of_beef_cattle
Cannabis use and mental health-related quality of life among individuals with depressive disorders. (Israel/ Germany/ Canada) (download – 2017) https://isiarticles.com/bundles/Article/pre/pdf/60067.pdf
Examining the relationship between medical cannabis laws and cardiovascular deaths in the US. (USA) (download – 2017) https://www.nber.org/papers/w22688.pdf
Association Between Plasma N-Acylethanolamides and High Hemoglobin Concentration in Southern Peruvian Highlanders. (Peru) (click “researchgate” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Association+Between+Plasma+N-Acylethanolamides+and+High+Hemoglobin+Concentration+in+Southern+Peruvian+Highlanders.&btnG
Cannabis use, COMT, BDNF and age at first-episode psychosis. (Spain) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28142064
Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency Setting. (USA) (abst – 2017) http://www.tandfonline.com/doi/abs/10.1080/10826084.2016.1263663?journalCode=isum20
Marijuana and other substance use among male and female underage drinkers who drive after drinking and ride with those who drive after drinking. (USA/ Ukraine) (abst–2017) https://www.sciencedirect.com/science/article/abs/pii/S0306460317300801
Sex-dependent effects of neonatal maternal deprivation on endocannabinoid levels in the adipose tissue: influence of diet. (Spain/ Italy) (abst – 2017) https://link.springer.com/article/10.1007%2Fs13105-017-0558-0
https://www.semanticscholar.org/paper/Sex-dependent-effects-of-neonatal-maternal-on-in-of-Mela-Piscitelli/9c2211dd7e0242a366eb250e378d7de356f95c23
The Relation between Driving Violations and Health Promotion Behaviors among Undergraduate Students: Self-Report of Road Behavior. (Israel) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28409675
Sex- and hormone-dependent alterations in alcohol withdrawal-induced anxiety and corticolimbic endocannabinoid signaling. (USA/ Canada) (abst – 2017) https://www.semanticscholar.org/paper/Sex-and-hormone-dependent-alterations-in-alcohol-Henricks-Berger/129f03d7c57b76982786e278b8fee80eddb100d2 http://www.sciencedirect.com/science/article/pii/S0028390817302484
The Effects of Cannabidiol (CBD) on Δ9-Tetrahydrocannabinol (THC) Self- Administration in Male and Female Long-Evans Rats. (USA) (abst – 2017) https://www.semanticscholar.org/paper/The-effects-of-cannabidiol-(CBD)-on-(THC)-in-male-Wakeford-Wetzell/4140185bf4bfb025d3f8dfae9f132b30de580ffc
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles. (USA) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0306460317302721?via%3Dihub
https://www.semanticscholar.org/paper/DSM-5-cannabis-use-disorder-in-the-National-Survey-Kerridge-Pickering/c11711f19134a1b11d7aee2c3c64a10959b418e6
17β-Estradiol Potentiates the Reinstatement of Cocaine Seeking in Female Rats: Role of the Prelimbic Prefrontal Cortex and Cannabinoid Type-1 Receptors (USA) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28825421
Immunohistochemical localization of cannabinoid receptor 1 (CB1) in the submandibular gland of mice under normal conditions and when stimulated by isoproterenol or carbachol. (Thailand/ Japan) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0003996917301474
Gene variants and educational attainment in cannabis use: mediating role of DNA methylation. (USA/ Italy) (full – 2018) https://www.nature.com/articles/s41398-017-0087-1
Gender differences of cannabis smoking on serum leptin levels: population-based study. (Brazil) (full – 2018) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462018000200216
Nineteen and Up study (19Up): understanding pathways to mental health disorders in young Australian twins. (Australia/ USA/ UK) (full – 2018) http://bmjopen.bmj.com/content/8/3/e018959.long
Gender-specific association of functional prodynorphin 68 bp repeats with cannabis exposure in an African American cohort. (USA) (full – 2018) https://www.dovepress.com/gender-specific-association-of-functional-prodynorphin-68-bp-repeats-w-peer-reviewed-fulltext-article-NDT
Job exposure to the public in relation with alcohol, tobacco and cannabis use: Findings from the CONSTANCES cohort study. (France) (full – 2018) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0196330
Current Marijuana Use by Industry and Occupation — Colorado, 2014–2015. (USA) (full – 2018) https://www.cdc.gov/mmwr/volumes/67/wr/mm6714a1.htm?s_cid=mm6714a1_w
Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism. (Italy) (full – 2018) https://www.sciencedirect.com/science/article/pii/S2212877818303934?via%3Dihub
Who seeks treatment for cannabis use? Registered characteristics and physical, psychological and psychosocial problem indicators among cannabis patients and matched controls. (Norway) (full – 2018) https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-018-5625-0
Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with Schizophrenia: An Ecological Cross-Sectional Study. (Italy) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037576/
Endocannabinoid Signaling at Hypothalamic Steroidogenic Factor- 1/Proopiomelanocortin Synapses Is Sex- and Diet-Sensitive. (USA) (full – 2018) https://www.frontiersin.org/articles/10.3389/fnmol.2018.00214/full
Rolling and scrolling: The portrayal of marijuana cigars (blunts) on YouTube. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991612/
The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences. (Canada/ UK) (full – 2018) https://bsd.biomedcentral.com/articles/10.1186/s13293-018-0182-x
An Assessment of the Genotoxicity and Subchronic Toxicity of a Supercritical Fluid Extract of the Aerial Parts of Hemp. (USA/ Hungary) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011091/
Marijuana Use in Adults Living with Sickle Cell Disease. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044416/
Effects of an early life experience on rat brain cannabinoid receptors in adolescence and adulthood. (Greece) (full – 2018) https://www.sciencedirect.com/science/article/pii/S2451830117300511?via%3Dihub
Sex Difference: What does cannabis do to the brain before birth? (Switzerland) (full – 2018) https://elifesciences.org/articles/41229
Maternal high-fat diet consumption induces sex-dependent alterations of the endocannabinoid system and redox homeostasis in liver of adult rat offspring. (Brazil) (full – 2018) https://www.nature.com/articles/s41598-018-32906-0
Prevalence of Cannabis Use Among Medical Students: A Systematic Review and Meta- analysis. (Greece) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194916/
Analysis of trends in the prevalence of cannabis use in Canada, 1985 to 2015. (Canada) (full – 2018) https://www150.statcan.gc.ca/n1/pub/82-003-x/2018002/article/54908-eng.htm
The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity. (Italy) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212868/
Risk Factors Associated With Gambling Involvement among a National Sample of African American and European American Young Adults. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233904/
Sex-dependent effects of in utero cannabinoid exposure on cortical function. (France/ USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162091/
Disparities in substance use behaviors and disorders among adult sexual minorities by age, gender, and sexual identity. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083846
Marijuana Use and Depressive Symptoms; Gender Differences in African American Adolescents. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250838/
The association between depression, anxiety and substance use among Canadian post- secondary students. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260190/
Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295937/
Prevalence and Sociodemographic Correlates of Adolescent Use and Polyuse of Combustible, Vaporized, and Edible Cannabis Products. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324616/
Short-Term Genetic Selection for Adolescent Locomotor Sensitivity to Delta9- Tetrahydrocannabinol (THC). (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935564/
Marijuana use by intimate partners: Does discrepant use impair relationship functioning? (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013342/
Sex and age differences in risk factors of marijuana involvement during adolescence. (USA/ Taiwan) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891165/
Parental Divorce and Family History of Alcohol Disorder: Associations with Young Adults’ Alcohol Problems, Marijuana Use, and Interpersonal Relations. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984164/
Gender- and age-varying associations of sensation seeking and substance use across young adulthood. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314667/
Dual use of alcohol and marijuana and condomless sex in young adult men and women: A within-subject day-level analysis. (USA) (full – 2018) https://www.semanticscholar.org/paper/Dual-use-of-alcohol-and-marijuana-and-condomless-in-Hayaki-Anderson/ca52ec7a36c345326328b062e52b2efa49f6b84c
An Examination of the Impact of Childhood Emotional Abuse and Gender on Cannabis Use Trajectories among Community Youth. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005668/
Tobacco and cannabis use in college students are predicted by sex-dimorphic interactions between MAOA genotype and child abuse. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436599/
Sex specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signaling. (Italy) (full – 2018) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.14435
Associations of Father’s Lifetime Cannabis Use Disorder with Child’s Initiation of Cannabis Use, Alcohol Use, and Sexual Intercourse by Child Gender. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264895/
Additive drug-specific and sex-specific risks associated with co-use of marijuana and tobacco during pregnancy: Evidence from 3 recent developmental cohorts (2003-2015). (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116514/
Sex Differences in the Association Between Cannabis Use and Suicidal Ideation and Attempts, Depression, and Psychological Distress Among Canadians (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591888/
Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy- Induced Neuropathic Pain: Studies in Animal Models. (Kuwait) (full – 2018) https://www.hindawi.com/journals/prm/2018/5234943/
Effects of atopic dermatitis and gender on sebum lipid mediator and fatty acid profiles. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800162/
Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats (USA) (full  – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699758/
Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454895/
Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat . (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033332/
Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112616/
Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus- norepinephrine neurons and corticotropin releasing factor-mediated responses. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476636/
The “Jay-Dar” Phenomenon: Individuals Discriminate Cannabis Users from Nonusers Based Upon a Photograph. (USA) (link to PDF – 2018) https://www.researchgate.net/publication/326083593_The_Jay-Dar_Phenomenon_Individuals_Discriminate_Cannabis_Users_from_Nonusers_Based_Upon_a_Photograph
Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats (USA) (link to PDF – 2018) https://www.biorxiv.org/content/early/2018/05/30/172759.full.pdf+html
Relationships between substance abuse/dependence and psychiatric disorders based on polygenic scores. (Spain) (link to PDF – 2018) https://www.semanticscholar.org/paper/Associations-between-Polygenic-Risk-for-Psychiatric-Carey-Agrawal/7efd0879f4a8da6a6043f52cdf2dcb1dbe4958b7
Anxiety sensitivity components in relation to alcohol and cannabis use, motives, and problems in treatment-seeking cigarette smokers. (USA) (link to PDF – 2018) https://www.researchgate.net/publication/323636835_Anxiety_sensitivity_components_in_relation_to_alcohol_and_cannabis_use_motives_and_problems_in_treatment-seeking_cigarette_smokers
Stress responding in cannabis smokers as a function of trauma exposure, sex, and relapse in the human laboratory. (USA/ Australia) (link to PDF – 2018) https://www.researchgate.net/publication/322827696_Stress_responding_in_cannabis_smokers_as_a_function_of_trauma_exposure_sex_and_relapse_in_the_human_laboratory Differentiating the Drug Normalization Framework: A Quantitative Assessment of Cannabis Use Patterns, Accessibility, and Acceptability Attitudes among University Undergraduates. (Canada) (link to PDF – 2018) https://www.researchgate.net/publication/326005012_Differentiating_the_Drug_Normalization_Framework_A_Quantitative_Assessment_of_Cannabis_Use_Patterns_Accessibility_and_Acceptability_Attitudes_among_University_Undergraduates
Marijuana eCHECKUPTO GO: Effects of a personalized feedback plus protective behavioral strategies intervention for heavy marijuana-using college students. (USA) (link to PDF – 2018) https://www.researchgate.net/publication/325955440_Marijuana_eCHECKUPTO_GO_Effects_of_a_personalized_feedback_plus_protective_behavioral_strategies_intervention_for_heavy_marijuana-using_college_students
Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort. (UK/ Italy) (link to download–2018) addictiondomain.com Developmental pathways of adolescent cannabis use: Risk factors, outcomes and sex- specific differences. (USA) (click “researchgate” for download – 2018) https://scholar.google.com/scholar?q=%22Developmental+pathways+of+adolescent+cannabis+use:+Risk+factors,+outcomes+and+sex-specific+differences.%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the 2013 Canadian Tobacco, Alcohol and Drugs Survey. (Canada) (click “davidhammond” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Prevalence+of+problematic+cannabis+use+in+Canada%3A+Cross-sectional+findings+from+the+%092013+Canadian+Tobacco%2C+Alcohol+and+Drugs+Survey.++++%22&btnG
Sleep Disturbances, Psychosocial Difficulties and Health Risk Behaviour in 16,781 Dutch Adolescents. (Netherlands/ USA) (click “uunl” for download– 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Sleep+Disturbances%2C+Psychosocial+Difficulties+and+Health+Risk+Behaviour+in+16%2C781+%09Dutch+Adolescents.+&btnG
Relationship of media exposure to substance use among adolescents in Saudi Arabia: Results from a national study. (Saudi Arabia/ USA) (click “uswracir” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Relationship+of+media+exposure+to+substance+use+among+adolescents+in+Saudi+Arabia%3A+Results+from+a+national+study%22&btnG
Sex difference in brain CB1 receptor availability in man. (Finland/ UK/ USA) (click “researchgate” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Sex+difference+in+brain+CB1+receptor+availability+in+man&btnG
Bullying victimization and illicit drug use among students in Grades 7 to 12 in Manitoba, Canada: a cross-sectional analysis. (Canada) (abst in English & French – 2018) https://link.springer.com/article/10.17269%2Fs41997-018-0030-0
Trends in Daily Cannabis Use Among Cigarette Smokers: United States, 2002-2014. (USA/ Australia) (abst – 20 18) https://www.semanticscholar.org/paper/Trends-in-Daily-Cannabis-Use-Among-Cigarette-United-Goodwin-Pacek/2ed62c23a133348c66ddb09a5f4ed17571386745
Does Marijuana Use at Ages 16-18 Predict Initiation of Daily Cigarette Smoking in Late Adolescence and Early Adulthood? A Propensity Score Analysis of Add Health Data. (USA) (abst – 2018) https://www.semanticscholar.org/paper/Does-Marijuana-Use-at-Ages-16%E2%80%9318-Predict-Initiation-Nguyen-Ebnesajjad/60076b16d63052cafeb4af6618ebe265c784843b
Effects of CB1 receptor antagonism and stress exposures in adolescence on socioemotional behaviours, neuroendocrine stress responses, and expression of relevant proteins in the hippocampus and prefrontal cortex in rats . (Canada) (abst– 2018) https://www.sciencedirect.com/science/article/pii/S0028390817304963?via%3Dihub
https://www.semanticscholar.org/paper/Effects-of-CB1-receptor-antagonism-and-stress-in-on-Simone-Baumbach/bc3d224b98b487bd090e6aa26154bf91286e115b
“Are The Times A-Changin'”? Trends in Adolescent Substance Use in Europe. (Germany/ Sweden/ Hungary/ Italy/ Malta/ Netherlands/ Portugal/ Ireland/ Romania/ Belgium/ Slovakia/ Finland/ France/ Russia) (abst – 2018) https://www.semanticscholar.org/paper/%27Are-The-Times-A-Changin%27-Trends-in-adolescent-use-Kraus-Seitz/95603e21c854b467df225b760b9b33196918b01a
Pain interference and alcohol, nicotine, and cannabis use disorder in a national sample of substance users. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618301169
The effects of antipsychotics on the density of cannabinoid receptors in selected brain regions of male and female adolescent juvenile rats. (Australia) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0165178117315883
https://www.semanticscholar.org/paper/The-effects-of-antipsychotics-on-the-density-of-in-Lian-Deng/bf9af9cd9c04e19a93bb4b0e25a1082d364918a9
Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats. (Italy) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29595540
Sex differences in the cardiometabolic health of cannabis users with a psychotic illness. (Australia) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618305787?via%3Dihub
Cannabis use and knowledge among medical students at the University of the Free State, Bloemfontein, South Africa. (South Africa) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29642759
Attention deficit hyperactivity disorder and arrest history: Differential association of clinical characteristics by sex. (Canada) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29853005
Substance use and use disorders and treatment receipt among adults in families receiving Temporary Assistance for Needy Families (TANF), 2003-2014 (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318301849
Cohabitation, Marijuana Use, and Heavy Alcohol Use in Young Adulthood. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29924679
Borderline personality disorder features and drinking, cannabis, and prescription opioid motives: Differential associations across substance and sex. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318306361
A mediated multigroup model examining marijuana use consequences by sexual orientation in us college students. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318306646
Developmental and behavioral effects in neonatal and adult mice following prenatal activation of endocannabinoid receptors by capsaicin. (USA) (abst – 2018) https://www.nature.com/articles/s41401-018-0073-z
https://www.semanticscholar.org/paper/Developmental-and-behavioral-effects-in-neonatal-of-Perchuk-Bierbower/1c51c30dea30cd1fefa6bf2701d83f80fe594c11
Modulation of the endocannabinoid system by sex hormones: Implications for Posttraumatic Stress Disorder. (Australia) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0149763418301052
https://www.semanticscholar.org/paper/Modulation-of-the-endocannabinoid-system-by-sex-for-Ney-Matthews/bdb56b7bc3da50d8f96f88fb537aa37b79817ee2
Dating violence victimization and substance use: The role of a serotonin transporter gene polymorphism (5HTTLPR). (USA) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618303090
Sex-specific effects of CB1 receptor antagonism and stress in adolescence on anxiety, corticosterone concentrations, and contextual fear in adulthood in rats. (Canada) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0736574818301758?via%3Dihub
Gene Expression of ABHD6, a Key Factor in the Endocannabinoid System, Can Be Modulated by Female Hormones in Human Immune Cells (Brazil) (abst – 2018) https://link.springer.com/article/10.1007%2Fs10528-018-9871-8
Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors in rats. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618307580
First Time Cannabis Use and Sexual Debut in U.S. High School Adolescents. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S1054139X18304026
Shyness, social anxiety, social anxiety disorder, and substance use among normative adolescent populations: A systematic review. (Canada) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30422012
Community variation in adolescent cannabis use in Australia and the Netherlands. (Australia/ Netherlands) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318308670?via%3Dihub
Regulate yourself: Emotion regulation and protective behavioral strategies in substance use behaviors. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318310001?via%3Dihub
Associations between marijuana use and anxious mood lability during adolescence. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318311729?via%3Dihub
Enhancing effects of acute exposure to cannabis smoke on working memory performance. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563837/
Cannabinoid and nicotine exposure during adolescence induces sex-specific effects on anxiety- and reward-related behaviors during adulthood. (Netherlands/ USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354968/
Differences in Substance Use Disparities Across Age Groups in a National Cross- Sectional Survey of Lesbian, Gay, and Bisexual Adults. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434594/
Substance use behaviors and the timing of family formation during young adulthood. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380513/
Perceived Racial Discrimination and Marijuana Use a Decade Later; Gender Differences Among Black Youth. (USA) (full – 2019) https://www.frontiersin.org/articles/10.3389/fped.2019.00078/full
Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9- Tetrahydrocannabinol Administration in Humans. (UK/ Belgium) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523579/
Hypothalamic endocannabinoids inversely correlate with the development of diet- induced obesity in male and female mice. (Spain) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602126/
Sex differences in stress and immune responses during confinement in Antarctica. (Germany/ USA) (full – 2019) https://bsd.biomedcentral.com/articles/10.1186/s13293-019-0231-0
How Cannabis Alters Sexual Experience: A Survey of Men and Women. (Canada) (full – 2019) https://www.jsm.jsexmed.org/article/S1743-6095(19)31329-3/fulltext
Drivers who tested positive for cannabis in oral fluid: a longitudinal analysis of administrative data for Spain between 2011 and 2016. (Spain) (full – 2019) https://bmjopen.bmj.com/content/9/8/e026648.long
In the face of stress: Interpreting individual differences in stress-induced facial expressions. (Sweden) (full – 2019) https://www.sciencedirect.com/science/article/pii/S2352289518300985
Noradrenergic depletion causes sex specific alterations in the endocannabinoid system in the Murine prefrontal cortex. (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S2352289519300013?via%3Dihub
Beyond the Activity-Based Anorexia Model: Reinforcing Values of Exercise and Feeding Examined in Stressed Adolescent Male and Female Mice. (France) (full – 2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00587/full
Ontogeny and programming of the fetal temporal cortical endocannabinoid system by moderate maternal nutrient reduction in baboons (Papio spp.). (USA) (full – 2019) https://physoc.onlinelibrary.wiley.com/doi/full/10.14814/phy2.14024
Sex differences in distribution of cannabinoid receptors (CB1 and CB2), S100A6 and CacyBP/SIP in human ageing hearts. (Poland) (full – 2019) https://bsd.biomedcentral.com/articles/10.1186/s13293-018-0209-3
Substance use is independently associated with pneumonia severity in persons living with the human immunodeficiency virus (HIV). (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751019/
Beta-caryophyllene enhances wound healing through multiple routes. (USA) (full – 2019) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0216104
Older Cannabis Users Are Not All Alike: Lifespan Cannabis Use Patterns. (USA) (full – 2019) https://journals.sagepub.com/doi/full/10.1177/0733464819894922?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed Endocannabinoids and Fear-Related Behavior in Mice Selectively Bred for High or Low Alcohol Preference. (USA) (full – 2019) https://www.mdpi.com/2076-3425/9/10/254/htm
Gender differences among cannabis self-cultivators in Spain. (Spain) (link to PDFs in English & Spanish – 2019) http://adicciones.es/index.php/adicciones/article/view/1142
Analysis of trends in the prevalence of cannabis use and related metrics in Canada. (Canada) (link to download – 2019) https://www150.statcan.gc.ca/n1/pub/82-003-x/2019006/article/00001-eng.pdf
Effects of cannabidiol in males and females in two different rat models of depression. (Israel/ USA) (click “researchgate” for download – 2019) https://scholar.google.com/scholar?q=%22Effects+of+cannabidiol+in+males+and+females+in+two+different+rat+models+of+depression%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease. (Belgium/ South Africa/ Canada/ USA/ Switzerland/ Japan/ Netherlands/ Taiwan/ India/ Argentina/ Norway/ Sweden/ Malta/ France/ Australia/ Italy) (abst in English & French – 2019) https://www.onlinecjc.ca/article/S0828-282X(19)31150-X/fulltext
Sex differences in stress reactivity after intranasal oxytocin in recreational cannabis users. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0091305718303599
Prevalence and determinants of tobacco, e-cigarettes, and cannabis use among nursing students: A multicenter cross-sectional study. (Spain) (abst – 20 19) https://www.sciencedirect.com/science/article/pii/S026069171831075X
Sexual Minority Youth at Risk of Early and Persistent Alcohol, Tobacco, and Marijuana Use. (USA) (abst – 2019) https://link.springer.com/article/10.1007%2Fs10508-018-1275-7
Altered striatal reward processing in abstinent dependent cannabis users: Social context matters. (China/ Germany) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30658938
PTSD Symptom Severity, Cannabis, and Gender: A Zero-Inflated Negative Binomial Regression Model. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30767607
Prevalence and correlates of medical cannabis patients’ use of cannabis for recreational purposes. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318311419
Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis. (Canada/ USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30807448
Pubertal Timing and Substance use in Adolescence: an Investigation of Two Cognitive Moderators. (USA) (abst – 2019) https://link.springer.com/article/10.1007%2Fs10802-019-00524-7
Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004-2013. (USA) (abst – 2019) https://link.springer.com/article/10.1007%2Fs11121-017-0848-3
Cross-cultural examination of college marijuana culture in five countries: Measurement invariance of the Perceived Importance of Marijuana to the College Experience Scale. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318314394?via%3Dihub
Characteristics Associated with Attitudes toward Marijuana Legalization in Michigan. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31092135
Age, period and cohort effects in frequent cannabis use among US students: 1991-2018. (USA) (abst – 2019) https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14665
Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31120286
The effects of sex and residual cannabis use on emotion processing: An event-related potential study. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31204825
Marijuana use among patients with epilepsy at a tertiary care center. (USA) (abst – 2019) https://www.epilepsybehavior.com/article/S1525-5050(19)30222-7/fulltext
Salivary endocannabinoids as mediators in the relationship between omega-6 and omega- 3 fatty acid ratio intake from highly-processed foods and anthropometric markers of health in women. (Germany/ Spain) (abst – 2019) https://www.tandfonline.com/doi/abs/10.1080/09637486.2019.1632274?journalCode=iijf20
Chronic aerobic exercise: Lack of effect on brain CB1 receptor levels in adult rats. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S002432051930414X?via%3Dihub
Maternal high-fat diet impairs leptin signaling and up-regulates type-1 cannabinoid receptor with sex-specific epigenetic changes in the hypothalamus of newborn rats (Brazil/ USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306453018308412?via%3Dihub
State-level marijuana policies and marijuana use and marijuana use disorder among a nationally representative sample of adults in the United States, 2015-2017: Sexual identity and gender matter. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0376871619302650
Marijuana smoking and outcomes of infertility treatment with assisted reproductive technologies. (USA) (abst – 2019) https://academic.oup.com/humrep/article-abstract/34/9/1818/5549505?redirectedFrom=fulltext
Perception and practices regarding cannabis consumption in Karachi, Pakistan: A cross- sectional study. (Pakistan) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31566085
Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity. (Canada) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0376871619303643?via%3Dihub
Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004-2013. (USA) (abst – 2019) https://link.springer.com/article/10.1007%2Fs11121-017-0848-3
Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults. (Canada) (abst – 2019) https://link.springer.com/article/10.1007%2Fs00213-019-05369-y
Vaporized Cannabis differentially modulates sexual behavior of female rats according to the dose. (Uruguay) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0091305719302187?via%3Dihub
Adverse events following Cannabis for medical use in Tuscany: an analysis of the Italian Phytovigilance database. (Italy) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31656045
Sex-specific behavioral deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 depend on mGlu5 receptor signaling. (Italy/ France/ USA) (abst – 2019) https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.14879
Marijuana use among patients with epilepsy at a tertiary care center. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1525505019302227
Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31712969
Short- and Long-Term Effects of Cannabis on Headache and Migraine. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31715263
Demographic differences in perceived social norms of drug and alcohol use among Hispanic/Latinx and non-Hispanic White college students. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460319302047
Patterns of gambling and substance use initiation in African American and White adolescents and young adults. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31750700
The effect of high maternal linoleic acid on endocannabinoid signalling in rodent hearts. (Australia) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31814560
Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping. (Italy/ Israel) (abst – 2019) https://onlinelibrary.wiley.com/doi/abs/10.
1002/dev.21944 Human Pharmacokinetic Parameters of Orally Administered Δ9-Tetrahydrocannabinol Capsules Are Altered by Fed Versus Fasted Conditions and Sex Differences. (Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31872060
Sex and Gender Interactions on the Use and Impact of Recreational Cannabis. (Canada) (full – 2020) https://www.mdpi.com/1660-4601/17/2/509/htm
Russian Federation medical student knowledge, attitudes and beliefs toward medical cannabis. (Russia/ Israel) (full – 2020) https://www.sciencedirect.com/science/article/pii/S0965229919316371
Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats. (USA/ India) (full – 2020) https://www.sciencedirect.com/science/article/pii/S0022395619307356?via%3Dihub
Intergenerational congruence in adolescent onset of alcohol, tobacco, and marijuana use. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31916782
Marijuana Decriminalization, Medical Marijuana Laws, and Fatal Traffic Crashes in US Cities, 2010-2017. (USA) (abst – 2020) https://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2019.305484
Harmful drinking, tobacco, and marijuana use in the 2000-2015 National Alcohol Surveys: Examining differential trends by sexual identity. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31951792
Perceived Ease of Access and Age Attenuate the Association Between Marijuana Ad Exposure and Marijuana Use in Adolescents. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31958996
An evaluation of the anti‐hyperalgesic effects of cannabidiolic acid‐methyl ester (CBDA‐ ME) in a preclinical model of peripheral neuropathic pain. (Canada/ Israel) (abst – 2020) https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.14997
Substance use in Roma population in contact with social workers in the Czech Republic: A cross-sectional questionnaire survey. (Czech Republic) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31990239
Gender Norms, Roles and Relations and Cannabis-Use Patterns: A Scoping Review. (Canada) (abst – 2020) https://www.mdpi.com/1660-4601/17/3/947/htm
Appearance-related teasing and substance use during early adolescence. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/32039619


SEXUAL ABUSE
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students. (USA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/artsicles/PMC5101100/
Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment. (France/ USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581875/
Cannabis Use and Hypomania in Young People: A Prospective Analysis (UK) (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192498/ Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575989/
Social Stress and Substance Use Disparities by Sexual Orientation Among High School Students. (USA) (link to PDF– 2017) https://www.researchgate.net/publication/319199948_Social_Stress_and_Substance_Use_Disparities_by_Sexual_Orientation_Among
_High_School_Students Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity? (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545193/
Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse. (USA/ Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557140/
Regular past year cannabis use in women veterans and associations with sexual trauma. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716375/
Influence of the type of childhood violence on cannabis abuse and dependence among adolescents: a systematic review and meta-analysis. (Mexico) (links to PDFs in Spanish & English– 2018) http://adicciones.es/index.php/adicciones/article/view/1050
Risk and Protective Factors for Substance Use Among Youth Experiencing Homelessness. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31827311
Sexual risk classes among youth experiencing homelessness: Relation to childhood adversities, current mental symptoms, substance use, and HIV testing. (USA) (full – 2020) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0227331
Experiencing sexual harassment by males and associated substance use & poor mental health outcomes among adolescent girls in the US. (USA) (full – 2020) https://www.sciencedirect.com/science/article/pii/S2352827318302842


SEXUAL MINORITIES
Where you live matters: Structural correlates of HIV risk behavior among young men who have sex with men in Metro Detroit. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248557/
(abst in English and Spanish – 2015) https://link.springer.com/article/10.1007%2Fs10461-015-1180-1
Gender minority social stress in adolescence: disparities in adolescent bullying and substance use by gender identity. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201643/
Structural Stigma and Sexual Orientation Disparities in Adolescent Drug Use. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395540/
Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447557/
Sexual orientation disparities in psychiatric and drug use disorders among a nationally representative sample of women with alcohol use disorders. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417371/
An alcohol, tobacco, and other drug use comparison of lesbian, bisexual, and heterosexual undergraduate women. (USA) (link to PDF – 2015) https://www.researchgate.net/publication/269466733_An_Alcohol_Tobacco_and_Other_Drug_Use_Comparison_of_Lesbian_Bisexu
al_and_Heterosexual_Undergraduate_Women Adolescent Sexual Minority Girls Are at Elevated Risk for Use of Multiple Substances. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888964/
Substance use among adolescent sexual minority athletes: A secondary analysis of the youth risk behavior survey. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835837/
Identifying HIV care enrollees at-risk for cannabis use disorder. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573588/
Substance Use Among Sexual Minority Collegiate Athletes: A National Study. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835837/
The curvilinear effects of sexual orientation on young adult substance use. (USA) (download – 2016) The curvilinear effects of sexual orientation on young adult substance … Sexual orientation, minority stress, social norms, and substance use among racially diverse adolescents. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575887/
Demographic Characteristics, Components of Sexuality and Gender, and Minority Stress and Their Associations to Excessive Alcohol, Cannabis, and Illicit (Noncannabis) Drug Use Among a Large Sample of Transgender People in the United States. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516932/
Social Stress and Substance Use Disparities by Sexual Orientation Among High School Students. (USA) (link to PDF– 2017) https://www.researchgate.net/publication/319199948_Social_Stress_and_Substance_Use_Disparities_by_Sexual_Orientation_Among_High_School_Students
Daily-level associations between PTSD and cannabis use among young sexual minority women. (USA) (link to PDF – 2017) https://www.researchgate.net/publication/317424016_Daily-level_associations_between_PTSD_and_cannabis_use_among_young_sexual_minority_women
Sexual orientation disparities in the co-occurrence of substance use and psychological distress: a national population-based study (2008-2015). (USA/ Sweden) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862943/
A three-city comparison of drug use and drug use before sex among young men who have sex with men in the United States. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205241/
Violence Victimization, Substance Use, and Suicide Risk Among Sexual Minority High School Students – United States, 2015-2017. (USA) (full – 2018) https://www.cdc.gov/mmwr/volumes/67/wr/mm6743a4.htm?s_cid=mm6743a4_w
Disparities in substance use behaviors and disorders among adult sexual minorities by age, gender, and sexual identity. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083846
Substance Use Among Lesbian, Gay, Bisexual, and Questioning Adolescents in the United States, 2015. (USA/ Ireland) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050864/
Effects of romantic involvement on substance use among young sexual and gender minorities. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348899/
Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse. (USA/ Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557140/
Regular past year cannabis use in women veterans and associations with sexual trauma. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716375/
Supporting Transgender and Gender Diverse Youth: Protection Against Emotional Distress and Substance Use. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501838/
Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1 Infection. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692862/
Prevalence of Substance Use among Lesbian, Gay, Bisexual, and Transgender Youth in Military Families: Findings from the California Healthy Kids Survey. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29303404
Prevalence and Correlates of Substance Use in Homeless Youth and Young Adults. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29505458

A mediated multigroup model examining marijuana use consequences by sexual orientation in us college students. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318306646
Exposure to community violence and substance use among Black men who have sex with men: examining the role of psychological distress and criminal justice involvement. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30280579
Effects of victimization on mental health and substance use trajectories in young sexual minority men. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30585567
Differences in Substance Use Disparities Across Age Groups in a National Cross- Sectional Survey of Lesbian, Gay, and Bisexual Adults. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434594/
Dealing with gender-related and general stress: Substance use among Brazilian transgender youth. (Brazil/ Canada) (full – 2019) https://www.sciencedirect.com/science/article/pii/S2352853218301895
Sexual Minority Youth at Risk of Early and Persistent Alcohol, Tobacco, and Marijuana Use. (USA) (abst – 2019) https://link.springer.com/article/10.1007%2Fs10508-018-1275-7
Sexual minority women and Cannabis use: The serial impact of PTSD symptom severity and coping motives. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318307275?via%3Dihub
Substance Use and School Characteristics in Lesbian, Gay, Bisexual, and Heterosexual High School Students. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30637738
Not getting high with a little help from your friends: Social versus drug network correlates of marijuana use among YMSM. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318308244?via%3Dihub
A longitudinal analysis of cannabis use and mental health symptoms among gay, bisexual, and other men who have sex with men in Vancouver, Canada. (Canada/ USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0165032718319293?via%3Dihub
Does the association between substance use and sexual risk behaviors among high school students vary by sexual identity? (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318307627?via%3Dihub
Adverse childhood experiences and MSM marijuana use. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0376871619300572?via%3Dihub
Associations Between Cannabis Use, Sexual Behavior, and Sexually Transmitted Infections/Human Immunodeficiency Virus in a Cohort of Young Men Who Have Sex With Men. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30640212
State-level marijuana policies and marijuana use and marijuana use disorder among a nationally representative sample of adults in the United States, 2015-2017: Sexual identity and gender matter. (USA) (abst – 2019) 
https://www.sciencedirect.com/science/article/abs/pii/S0376871619302650
Sexual minority substance use disparities: Bisexual women at elevated risk relative to other sexual minority groups. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0376871619305320?via%3Dihub
Risk and Protective Factors for Substance Use Among Youth Experiencing Homelessness. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31827311
Sexual risk classes among youth experiencing homelessness: Relation to childhood adversities, current mental symptoms, substance use, and HIV testing. (USA) (full – 2020) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0227331
Sex and Gender Interactions on the Use and Impact of Recreational Cannabis. (Canada) (full – 2020) https://www.mdpi.com/1660-4601/17/2/509/htm
Differences in 30-Day Marijuana Use by Sexual Orientation Identity: Population-Based Evidence from Seven States. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31939720
Harmful drinking, tobacco, and marijuana use in the 2000-2015 National Alcohol Surveys: Examining differential trends by sexual identity. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31951792
Characterization of substance use among underrepresented sexual and gender minority participants in The Population Research in Identity and Disparities for Equality (PRIDE) Study. (USA) (abst – 2020) https://www.tandfonline.com/doi/full/10.1080/08897077.2019.1702610
Gender Norms, Roles and Relations and Cannabis-Use Patterns: A Scoping Review. (Canada) (abst – 2020) https://www.mdpi.com/1660-4601/17/3/947/htm
Between Pleasure and Pain: A Pilot Study on the Biological Mechanisms Associated With BDSM Interactions in Dominants and Submissives. (Belgium) (abst – 2020) https://www.jsm.jsexmed.org/article/S1743-6095(20)30026-6/fulltext


SICKLE CELL DISEASE+
The Use of Marijuana and Hydroxyurea Among Sickle Cell Patients. (USA) (full – 2015) http://www.bloodjournal.org/content/128/22/5913?sso-checked=true
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004356/
Quantification of pain in sickle mice using facial expressions and body measurements. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746724/

Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report. (USA) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26956672
The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627667/
Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561456/
Marijuana Use in Adults Living with Sickle Cell Disease. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044416/
Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study. (USA) (full – 2019) https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2734070
Updated mechanisms underlying sickle cell disease-associated pain. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0304394019305749


SINUSITIS
Cannabis and crossed allergy with food. (France) (abst in English & French – 2017) http://www.em-consulte.com/article/1183746/alertePM
Endocannabinoid receptor CB2R is significantly expressed in aspirin-exacerbated respiratory disease: a pilot study. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310126/
Impact of habitual marijuana and tobacco smoke on severity of chronic rhinosinusitis. (Egypt) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0196070919302881?via%3Dihub


SKIN
Lipid mediator profile in vernix caseosa reflects skin barrier development. (Sweden) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629127/
Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541500/
Flax Fiber Hydrophobic Extract Inhibits Human Skin Cells Inflammation and Causes Remodeling of Extracellular Matrix and Wound Closure Activation. (Poland) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539444/
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content. (Pakistan) (link to download– 2015) The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content Cannabinoid CB2 receptors are involved in the regulation of fibrogenesis during skin wound repair in mice. (China) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805070/
Mustard vesicants alter expression of the endocannabinoid system in mouse skin. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947375/
Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing. (China) (full – 2016) https://journal-inflammation.biomedcentral.com/articles/10.1186/s12950-018-0201-z
Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment. (Hungary/ Germany/ UK) (click “unideb” for download – 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Differential+effectiveness+of+selected+non%E2%80%90psychotropic+phytocannabinoids+on+human+sebocyte+functions+implicates+their+introduction+in+dry%2Fseborrhoeic+skin+and+acne+tre atment%22&btnG
Dermatological Aspects of Synthetic Cannabinoid Addiction. (Turkey) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27028361
Comparison of protective effect of ascorbic acid on redox and endocannabinoid systems interactions in in vitro cultured human skin fibroblasts exposed to UV radiation and hydrogen peroxide. (Poland) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387039/
Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on cutaneous ceramides, in a human skin organ culture model. (UK) (full – 2017) http://www.sciencedirect.com/science/article/pii/S0005273617300986
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (Hungary) (full – 2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext
The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice. (Japan) (abst – 2017) https://www.karger.com/Article/Abstract/455916
https://www.semanticscholar.org/paper/The-Inhibitory-Effect-of-S-777469%2C-a-Cannabinoid-2-Haruna-Soga/1caea50bcadc287a83cebafa8e99429bb1f8e776
Lipidomics for translational skin research: a primer for the uninitiated. (UK) (full – 2018) https://onlinelibrary.wiley.com/doi/abs/10.1111/exd.13558
Skin Prick Test Reactivity to Common Aeroallergens among Allergic Rhinitis Patients (Pakistan/ Saudi Arabia) (link to download – 2018) Skin Prick Test Reactivity to Common Aeroallergens among Allergic Rhinitis Cannabinoid receptor types 1 and 2 and peroxisome proliferator-activated receptor-α: distribution in the skin of clinically healthy cats and cats with hypersensitivity dermatitis. (Italy) (abst – 2018) https://onlinelibrary.wiley.com/doi/full/10.1111/vde.12658
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. (Spain/ Italy/ USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303484
https://www.semanticscholar.org/paper/The-endocannabinoid-system-of-the-skin.-A-potential-R%C3%ADo-Mill%C3%A1n/ee3c98a6a53a85c6f4bbd71bab445769ae791e32
Fatty acids and related lipid mediators in the regulation of cutaneous inflammation. (UK) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29330355
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System. (Hungary) (full – 2019) https://www.mdpi.com/1420-3049/24/5/918/htm
Modulators of the endocannabinoid system influence skin barrier repair, epidermal proliferation, differentiation and inflammation in a mouse model (Germany) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31350927


SLEEP APNEA+
Emerging Drugs for Common Conditions of Sleepiness: Obstructive Sleep Apnea and Narcolepsy. (USA) (abst – 2015) http://www.tandfonline.com/doi/full/10.1517/14728214.2015.1115480
Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea. (China) (full – 2016) http://www.hindawi.com/journals/bmri/2016/9782031/
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats. (USA) (full – 2016) http://jnrbm.biomedcentral.com/articles/10.1186/s12952-016-0052-1
Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague- Dawley Rats. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806547/
Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806568/
Cannabis, Cannabinoids, and Sleep: a Review of the Literature. (USA) (link to download – 2017) Cannabis, Cannabinoids, and Sleep: a Review of the Literature Cannabinoids as therapeutic for PTSD. (USA) (abst – 2017) http://www.sciencedirect.com/science/article/pii/S2352250X16302342
Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886446/
Cannabis Oil in an Irish Children’s Critical Care Unit. (Ireland) (full – 2018) http://imj.ie/cannabis-oil-in-an-irish-childrens-critical-care-unit/
Medical Cannabis and AASM Position Statement: The Don’t Ask, Don’t Tell Wishing Well. (USA) (letter – 2018) http://jcsm.aasm.org/ViewAbstract.aspx?pid=31418
Stop the Attack on Minnesota’s Courageous Stance to Allow Its Residents to Sleep Safely. (USA) (letter – 2018) http://jcsm.aasm.org/ViewAbstract.aspx?pid=31419
Medical Cannabis, Synthetic Marijuana Extracts, and Obstructive Sleep Apnea. (USA) (letter – 2018) http://jcsm.aasm.org/ViewAbstract.aspx?pid=31420
Role of the endogenous cannabinoid receptor 1 in brain injury induced by chronic intermittent hypoxia in rats. (China) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29264962


SLEEP DISORDERS/PARASOMNIAS
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845302/
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/artsicles/PMC5101100/
Prevalence of teenage sleeping disorders. (France) (abst in English & French – 2017) https://www.sciencedirect.com/science/article/pii/S0929693X17300350?via%3Dihub
Treatment of REM Sleep Behavior Disorder. (USA) (abst – 2017) https://link.springer.com/article/10.1007%2Fs11940-016-0433-2
Characteristics of socially withdrawn youth in France: A retrospective study. (France) (abst – 2017) https://journals.sagepub.com/doi/abs/10.1177/0020764017704474?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=ispa Exploring Interventions for Sleep Disorders in Adolescent Cannabis Users. (USA) (full – 2018) http://www.mdpi.com/2076-3271/6/1/11/htm
Therapeutic Symptomatic Strategies in the Parasomnias. (Italy) (abst – 2018) https://link.springer.com/article/10.1007%2Fs11940-018-0508-3
Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013 . (USA) (full – 2018) https://link.springer.com/article/10.1007%2Fs11920-018-0971-2

Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan). (Italy) (full – 2019) https://onlinelibrary.wiley.com/doi/full/10.1111/ijpp.12514
Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms. (USA/ Canada) (full – 2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0658?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. (Italy/ UK) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780141/
The use of cannabinoids for sleep: A critical review on clinical trials. (Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31120284
The Endocannabinoid System May Modulate Sleep Disorders In Aging. (Brazil) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31368874
Olfactory connectivity mediates sleep-dependent food choices in humans. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31591965
Novel object recognition memory in REM sleep-deprived rats: role of the cannabinoid CB1 receptor. (Iran) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31711896
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. (Australia/ UK) (full – 2020) https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-019-2409-8
Therapeutic Uses of Cannabis on Sleep Disorders and Related Conditions. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31895189
Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study. (Israel) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31959585


SLEEP MODULATION*+
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331066/
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup. (USA) (full – 2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. (UK/ Italy/ Netherlands/ Peru/ USA/ Germany) (full – 2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol. (USA/ Belgium) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763355/
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson’s Disease Patients in Colorado. (USA) (full – 2015) http://www.hindawi.com/journals/ecam/2015/874849/
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A systematic review of randomized controlled trials. (Canada/ Germany/ USA) (full – 2015) http://onlinelibrary.wiley.com/doi/10.1002/acr.22727/full
Rhythmic control of endocannabinoids in the rat pineal gland (Germany) (link to PDF–2015) https://www.researchgate.net/publication/278043955_Rhythmic_control_of_endocannabinoids_in_the_rat_pineal_gland
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials. (Canada) (link to PDF – 2015) https://www.researchgate.net/publication/273888773_Cannabinoids_for_the_Treatment_of_Chronic_Non-Cancer_Pain_An_Updated_Systematic_Review_of_Randomized_Controlled_Trials
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses. (Brazil) (link to PDF – 2015) https://www.researchgate.net/publication/271334260_Role_of_endocannabinoid_signalling_in_the_dorsolateral_periaqueductal_grey_in_the_modulation_of_distinct_panic-like_responses
The effects of chronic marijuana use on circadian entrainment. (USA) (link to PDF – 2015) https://www.researchgate.net/publication/274079017_The_effects_of_chronic_marijuana_use_on_circadian_entrainment
Cannabis withdrawal and sleep: A systematic review of human studies. (Australia) (click “upenn” for download – 2015) https://scholar.google.com/scholar?q=Cannabis+withdrawal+and+sleep:+A+systematic+review+of+human+studies.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. (USA) (click “semanticscholar” for download – 2015) https://scholar.google.com/scholar?q=%22Use+and+effects+of+cannabinoids+in+military+veterans+with+posttraumatic+stress+disorder+%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. (USA) (click “semanticscholar” for download – 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Perceived+efficacy+of+cannabidiol-enriched+cannabis+extracts+for+treatment+of+pediatric+epilepsy%3A+A+potential+role+for+infantile+spasms+and+Lennox- Gastaut+syndrome.%22&btnG
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (Canada) (summary–2015) https://reachfamilies.umn.edu/research/document/7805
(abst–2015) https://www.sciencedirect.com/science/article/pii/S0306453014004132

top

Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. (USA) (abst – 2015) https://www.sciencedirect.com/science/article/abs/pii/S0306460315002269
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children. (Germany) (abst – 2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Endocannabinoid Signaling Regulates Sleep Stability. (USA) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152473
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans. (Sweden/ Italy/ Germany) (full – 2016) https://www.sciencedirect.com/science/article/pii/S0306453016307156
The impact of drugs for multiple sclerosis on sleep. (Italy) (full – 2016) http://journals.sagepub.com/doi/full/10.1177/1352458516664034
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165161/
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845302/
Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289074/
Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and Maintenance of Wakefulness Test. (Australia) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155193/
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function. (USA) (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00355/full
Disturbances of sleep and circadian rhythms: novel risk factors for obesity. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070789/
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086262/
Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/artsicles/PMC5101100/
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention. (Israel) (link to PDF– 2016) https://www.researchgate.net/publication/306434890_Cannabinoids_and_post-
traumatic_stress_disorder_clinical_and_preclinical_evidence_for_treatment_and_prevention Endocannabinoids and sleep. (Mexico) (link to PDF – 2016) https://www.researchgate.net/publication/270971464_Endocannabinoids_and_sleep
Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis (Mexico/Brazil/Portugal/Lithuania/China) (link to PDF–2016) https://www.researchgate.net/publication/309158406_Revealing_the_role_of_the_endocannabinoid_system_modulators_SR141716A
_URB597_and_VDM-11_in_sleep_homeostasis Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study. (Israel) (click “academia” for download – 2016) https://scholar.google.com/scholar?q=Safety+and+Efficacy+of+Medical+Cannabis+Oil+for+Behavioral+and+Psychological+Symptoms+of+Dementia:+An-Open+Label,+Add-On,+Pilot+Study&hl=en&as_sdt=0&as_vis=1&oi=scholart
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice. (Hungary) (abst – 2016) https://link.springer.com/article/10.1007%2Fs00429-016-1214-0
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity. (Germany) (abst – 2016) http
://www.ncbi.nlm.nih.gov/pubmed/27160412 Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment  (USA) (abst–2016) https://www.sciencedirect.com/science/article/abs/pii/S0306460316302477
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit. (Canada) (abst – 2016) http://www.epilepsybehavior.com/article/S1525-5050(16)30334-1/fulltext
Contribution of health motive to cannabis use among high-school students. (France) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S0306460316302829
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor. (Australia) (abst – 2016) https://www.semanticscholar.org/paper/Regulation-of-fear-extinction-by-long-term-The-of-Bennett-Arnold/658b7036a90c41bc79e1c9f7c6951db893a1ea2e
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis. (abst – 2016) (Canada) http://www.msard-journal.com/article/S2211
-0348(16)30171-7/fulltext https://www.semanticscholar.org/paper/Attitudes-to-cannabis-and-patterns-of-use-among-Banwell-
Pavisian/d6b1312f0d1dca1ed8eef6859683fb35e9145d41 Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity. (Germany/ Spain) (abst – 2016) https://www.karger.com/Article/Abstract/445943
Recent legalization of cannabis use: effects on sleep, health, and workplace safety. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656354/
Daily associations between cannabis motives and consumption in emerging adults. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548614/
Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague- Dawley Rats. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806547/
Smoked marijuana attenuates performance and mood disruptions during simulated night shift work. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578830/
Peripheral Endocannabinoids Associated with Energy Expenditure in Native Americans of Southwestern Heritage. (USA/ Germany) (full – 2017) https://academic.oup.com/jcem/article/103/3/1077/4780813
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta- analysis. (Canada) (full – 2017) https://journals.lww.com/anesthesia-analgesia/Fulltext/2017/11000/Selective_Cannabinoids_for_Chronic_Neuropathic.32.aspx
Sleep continuity, architecture and quality among treatment-seeking cannabis users: An in-home, unattended polysomnographic study. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309181/
Effects of sleep on substance use in adolescents: a longitudinal perspective. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770246/
Becoming a Medical Marijuana User. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808850/
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. (USA/ Canada/ Italy) (full – 2017) https://www.nature.com/articles/npp2017162
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (USA) (full – 2017) https://www.nature.com/articles/npp2017130
Clinical Evidence for Utilizing Cannabinoids in the Elderly. (Israel) (link to PDF – 2017) https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications. (Israel) (link to PDF – 2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
The excitatory/inhibitory input to orexin/hypocretin neuron soma undergoes day/night reorganization. (Italy/ Switzerland) (link to PDF – 2017) https://www.researchgate.net/publication/318109152_The_excitatoryinhibitory_input_to_orexinhypocretin_neuron_soma_undergoes_daynight_reorganization
The endocannabinoid system modulating levels of consciousness, emotions and likely dream contents. (Mexico) (download – 2017) https://www.researchgate.net/publication/314102877_The_Endocannabinoid_System_Modulating_Levels_of_Consciousness_Emotions_and_Likely_Dream_Contents
Cannabis, Cannabinoids, and Sleep: a Review of the Literature. (USA) (link to download – 2017) https://www.med.upenn.edu/cbti/assets/user-content/documents/s11920-017-0775-9.pdf
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. (USA) (click “komornlaw” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Substitution+of+medical+cannabis+for+pharmaceutical+agents+for+pain%2C+anxiety%2C+and+sleep+&btnG
Drowsiness and uncommon fever in a child after cannabis ingestion. (France) (abst in English – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28751294
(abst in French – 2017 ) http://www.jle.com/fr/revues/abc/e-docs/drowsiness_and_uncommon_fever_in_a_child_after_cannabis_ingestion_310181/article.phtml
Prevalence of teenage sleeping disorders. (France) (abst in English & French – 2017) https://www.sciencedirect.com/science/article/pii/S0929693X17300350?via%3Dihub
Cannabinoids as therapeutic for PTSD. (USA) (abst – 2017) http://www.sciencedirect.com/science/article/pii/S2352250X16302342
Anandamide and 2-AG Are Endogenously Present within the Laterodorsal Tegmental Nucleus: Functional Implications for a role of eCBs in arousal. (Denmark) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0006899317301579?via%3Dihub
Cannabis and Cannabinoids for Chronic Pain. (USA) (abst – 2017) https://link.springer.com/article/10.1007%2Fs11926-017-0693-1
https://www.semanticscholar.org/paper/Cannabis-and-Cannabinoids-for-Chronic-Pain-Romero-Sandoval-Kolano/70553bf4f70581f2730facdc6714503e4f2028b4
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia. (Canada) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/29256923
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. (USA) (abst – 2017) https://www.researchgate.net/publication/314126850_Marijuana_and_other_cannabinoids_as_a_treatment_for_posttraumatic_stress_disorder_A_literature_review
Efficacy and safety of cannabis for treating children with refractory epilepsy. (UK) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Exploring Interventions for Sleep Disorders in Adolescent Cannabis Users. (USA) (full – 2018) http://www.mdpi.com/2076-3271/6/1/11/htm
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. (Brazil) (full – 2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00315/full
Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions. (USA) (full – 2018) http://www.mdpi.com/2305-6320/5/3/75/htm
A Cross-Sectional Study of Cannabidiol Users. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043845/
Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16). (Australia) (full – 2018) https://www.mja.com.au/journal/2018/209/5/medicinal-cannabis-australia-2016-cannabis-medicine-survey-cams-16
The Consumption of Cannabis by Fibromyalgia Patients in Israel. (Israel) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081591/
Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis. (Jamaica) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058192/
Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain. (USA) (full – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618307786
Cannabis for peripheral neuropathy: The good, the bad, and the unknown. (USA) (full – 2018) https://www.ccjm.org/content/85/12/943.long
Medicinal versus Recreational Cannabis Use among Returning Veterans. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037171/
Made from concentrate? A national web survey assessing dab use in the United States. (USA) (full – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618303375
Insomnia and Regulation of Sleep-Wake Cycle With Drugs Among Adolescent Risky Drinkers. (Australia) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134245/
Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476562/
Differential relationships between cannabis consumption and sleep health as a function of HIV status. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233990/
Endocannabinoid Anandamide Mediates the Effect of Skeletal Muscle Sphingomyelins on Human Energy Expenditure. (USA/ Germany) (full – 2018) https://academic.oup.com/jcem/article/103/10/3757/5063487
Practical considerations in medical cannabis administration and dosing. (Canada/ Czech Republic) (link to PDF – 2018) https://www.researchgate.net/publication/322257368_Practical_considerations_in_medical_cannabis_administration_and_dosing
Medical Cannabis for Older Patients. (Canada/ Germany) (link to PDF – 2018) https://www.researchgate.net/publication/329275718_Medical_Cannabis_for_Older_Patients
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders. (Israel) (link to PDF – 2018) https://www.researchgate.net/publication/325179753_Medical_Cannabis_for_Pediatric_Moderate_to_Severe_Complex_Motor_Disorders
The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial. (Mexico) (link to PDF – 2018) https://www.researchgate.net/publication/323831708_The_effect_of_nabilone_on_appetite_nutritional_status_and_quality_of_life_in_lung_cancer_patients_a_randomized_double-blind_clinical_trial
Systemic Injections of Cannabidiol Enhance Acetylcholine Levels from Basal Forebrain in Rats. (Mexico/ Portugal/ Brazil/ Germany/ Iceland/ Lithuania) (link to PDF – 2018) https://www.researchgate.net/publication/325600150_Systemic_Injections_of_Cannabidiol_Enhance_Acetylcholine_Levels_from_Basal_Forebrain_in_Rats
Cannabis Use in Individuals with Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado. (USA) (download – 2018)
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. (Israel) (click “researchgate” for download – 2018) https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5
Cannabis for Chronic Pain: Challenges and Considerations. (USA) (click “cedfoundation” for download – 2018) https://scholar.google.com/scholar?q=Cannabis+for+Chronic+Pain:+Challenges+and+Considerations.&hl=en&as_sdt=0&as_vis=1&oi=scholart
The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. (USA) (click “mmpmacom” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+therapeutic+effects+of+Cannabis+and+cannabinoids%3A+An+update+from+the+National+%09Academies+of+Sciences%2C+Engineering+and+Medicine+report.&btnG
Single center experience with medical cannabis in Gilles de la Tourette syndrome. (Israel) (click “cedfoundation” for download – 2018) https://scholar.google.com/scholar?cluster=15252200464493865282&hl=en&as_sdt=0,5
Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29659126
What do we know about the pharmacotheraputic management of insomnia in cannabis withdrawal: A systematic review. (Canada) (abst – 2018) https://www.semanticscholar.org/paper/What-do-we-know-about-the-pharmacotheraputic-of-in-Zhand-Milin/2e661eee35bc106b65ccf219c5d6792d05c7d2f9 Cannabidiol affects circadian clock core complex and its regulation in microglia cells. (France) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30307084
Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study. (Israel) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30540595
Cannabidiol in Anxiety and Sleep: A Large Case Series. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/
∆9-Tetrahydrocannabinol, a major marijuana component, enhances the anesthetic effect of pentobarbital through the CB1 receptor. (Japan) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314990/
Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms. (USA/ Canada) (full – 2019) https://www.liebertpub.com/doi/full/
10.1089/jpm.2018.0658?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726263/
Nabilone for the Treatment of Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness and Guidelines. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK546995/
Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0306453019310200
Medical Cannabis for Older Patients-Treatment Protocol and Initial Results. (Israel) (full – 2019) https://www.mdpi.com/2077-0383/8/11/1819/htm
Onset of Regular Cannabis Use & Young Adult Insomnia: An Analysis of Shared Genetic Liability. (USA) (full – 2019) https://academic.oup.com/sleep/advance-article/doi/10.1093/sleep/zsz293/5650373
Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804884/
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. (Italy/ UK) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780141/
Opportunities for cannabis in supportive care in cancer. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676264/
AM-251, A Cannabinoid Antagonist, Modifies the Dynamics of Sleep-Wake Cycles in Rats. (Hungary/ UK) (full – 2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00831/full
Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care. (USA) (download – 2019) Relationship of Cannabis Use to Patient-Reported Symptoms … Acute effect of vaporized Cannabis on sleep and electrocortical activity. (Uruguay/ Mexico) (click “fmededuuy” for download – 2019) https://scholar.google.com/scholar?q=Acute+effect+of+vaporized+Cannabis+on+sleep+and+electrocortical+activity.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Should Oncologists Recommend Cannabis? (USA) (article – 2019) https://link.springer.com/article/10.1007%2Fs11864-019-0659-9
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S2211034818305157
Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. (Israel) (abst – 2019) https://www.tandfonline.com/doi/abs/10.1080/13543784.2019.1561859?journalCode=ieid20
Triple comorbid trajectories of alcohol, cigarette, and marijuana use from adolescence to adulthood predict insomnia in adulthood. (USA/ Republic of Korea) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318306385?via%3Dihub
Cannabis Oil Use by Adolescents and Young Adults With Inflammatory Bowel Disease. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30801394
Early adolescent drinking and cannabis use predicts later sleep-quality problems. (Australia) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30869923
Insomnia symptoms, cannabis protective behavioral strategies, and hazardous cannabis use among U.S. college students. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30907602
The use of cannabinoids for sleep: A critical review on clinical trials. (Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31120284
Illegal cannabis use is common among Danes with multiple sclerosis. (Denmark) (abst – 2019) https://www.msard-journal.com/article/S2211
-0348(19)30212-3/fulltext Cannabis and alcohol use for sleep aid: A daily diary investigation. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31169378
Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31264536
Cannabis Expectancies for Sleep. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31319769
The Endocannabinoid System May Modulate Sleep Disorders In Aging. (Brazil) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31368874
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31207606
Olfactory connectivity mediates sleep-dependent food choices in humans. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31591965
Utilization of medicinal cannabis for pain by individuals with spinal cord injury. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31632724
Onset of regular cannabis use and adult sleep duration: Genetic variation and the implications of a predictive relationship. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0376871619302765
Perceived Efficacy of Medical Cannabis in the Treatment of Co-Occurring Health- Related Quality of Life Symptoms. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31693457
Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31711352
Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey. (Australia) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31722852
Using recreational cannabis to treat insomnia: Evidence from over-the-counter sleep aid sales in Colorado. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0965229919308027?via%3Dihub
Cannabis Use in Children With Pantothenate Kinase-Associated Neurodegeneration. (USA) (abst – 2019) https://journals.sagepub.com/doi/abs/10.1177/0883073819890516?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=jcna Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey. (Poland/ Germany) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31872061
Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand. (New Zealand) (link to PDF- 2020) https://www.researchgate.net/publication/339046590_Cannabidiol_prescription_in_clinical_practice_an_audit_on_the_first_400_patients_in_New_Zealand
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients. (Israel) (link to download – 2020) https://www.rmmj.org.il/userimages/1036/1/PublishFiles/1038Article.pdf
Therapeutic Uses of Cannabis on Sleep Disorders and Related Conditions. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31895189
Is time elapsed between cannabis use and sleep start time associated with sleep continuity? An experience sampling method. (Israel) (abst – 2020) https://www.sciencedirect.com/science/article/abs/pii/S0376871620300119

Association Between Substance Use and Insufficient Sleep in U.S. High School Students. (USA) (abst- 2020) https://www.ncbi.nlm.nih.gov/pubmed/31971053
Negative mood as a mediator of the association between insomnia severity and marijuana problems in college students. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31997499
Dietary intake of polyunsaturated fatty acids alleviates cognition deficits and depression- like behaviour via cannabinoid system in sleep deprivation rats. (China) (abst – 2020) https://www.sciencedirect.com/science/article/pii/S0166432819317218


SMALLPOX+
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (Austria – full–2015) http://www.hindawi.com/journals/mi/2015/349176/

top


SMELL/OLFACTORY SYSTEM/ODOR DETECTION+
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons. (USA) (full – 2015) http://www.mdpi.com/1660-4601/13/1/5/htm
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485596/
Detection of Illicit Drugs by Trained Honeybees (Apis mellifera). (Germany) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471073/
A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients. (Canada) (click “researchgate” for download – 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22A+state-of-the-
art+review+of+the+management+and+treatment+of+taste+and+smell+alterations+in+adult+oncology+patients.+++++++%22&btnG
A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients. (Canada) (click “researchgate” for download – 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22A+state-of-the-
art+review+of+the+management+and+treatment+of+taste+and+smell+alterations+in+adult+oncology+patients.+++++++%22&btnG
A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women (Spain) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148734
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid. (Italy) (full – 2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse olfactory epithelium. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973592/
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit. (China) (download – 2016) Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced … Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain. (Italy) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26996621
Effects of analgesics on olfactory function and the perception of intranasal trigeminal stimuli. (Germany) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27320501
The role of the endocannabinoid system in the antihyperalgesic effect of Cedrus atlantica essential oil inhalation in a mouse model of postoperative pain. (Brazil) (full – 2017) http://www.sciencedirect.com/science/article/pii/S0378874117320172
Learning-induced modulation of the effect of endocannabinoids on inhibitory synaptic transmission. (Israel) (full – 2017) https://www.physiology.org/doi/full/10.1152/jn.00623.2017?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to Supercritical CO2 Concentrate. (USA) (full – 2017) https://www.academia.edu/34819120/Evaluation_of_Cannabinoid_and_Terpenoid_Content_Cannabis_Flower_Compared_to_Supercritical_CO_2_Concentrate
Effects of oral Δ9-tetrahydrocannabinol on the cerebral processing of olfactory input in healthy non-addicted subjects. (Germany) (click “researchgate” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Effects+of+oral+%CE%949-
tetrahydrocannabinol+on+the+cerebral+processing+of+olfactory+input+in+healthy+non-addicted+subjects.&btnG
Neuromodulation of Synaptic Transmission in the Main Olfactory Bulb (USA) (full–2018) https://www.mdpi.com/1660-4601/15/10/2194/htm
Consumer perceptions of strain differences in Cannabis aroma. (USA) (full – 2018) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192247
The Terroir of Cannabis: Terpene Metabolomics as a Tool to Understand Cannabis sativa Selections. (Canada) (link to PDF – 2019) https://www.semanticscholar.org/paper/The-Terroir-of-Cannabis%3A-Terpene-Metabolomics-as-a-Mudge-Brown/8b11b57bf0d163239d527c66d5d65098d216a897
CB1 Receptors in the Anterior Piriform Cortex Control Odor Preference Memory. (France/ Spain) (abst–2019) https://www.sciencedirect.com/science/article/abs/pii/S0960982219307687
Olfactory connectivity mediates sleep-dependent food choices in humans (USA) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31591965
Potential new therapies against a toxic relationship: neuroinflammation and Parkinson’s disease (Brazil/Spain) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31703030

top


SMOKED CANNABIS AS A MEDICATION*+
Chronic recurring uveitis / iritis responds to cannabis. (USA) (case report – undated) http://www.cannabisclinicians.org/resources/case-reports/?gv_search=iritis&filter_31=&mode=any
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. (Canada/ Germany) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440298/
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials. (Canada) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). (France) (full – 2015) http://cid.oxfordjournals.org/content/61/1/40.long
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis. (Israel) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519555/
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. (USA) (full – 2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Self-medication of achalasia with cannabis, complicated by a cannabis use disorder. (France) (full – 2015) http://www.wjgnet.com/1007-9327/full/v21/i20/6381.htm
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia. (Spain) (full – 2015) http://neuro.psychiatryonline.org/doi/full/10.1176/appi.neuropsych.12120398
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience. (Israel) (full – 2015) http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801109/
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (Iran/ UK) (full – 2015) http://link.springer.com/article/10.1007%2Fs13311-015-0367-5
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536087/
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. (USA/ Canada) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666747/
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950932/
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). (Canada) (full – 2015) http://www.jpain.org/article/S1526-5900(15)00837-8/fulltext
Is cannabis use associated with less opioid use among people who inject drugs? (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509857/
High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasis. (USA/ Central African Republic) (download – 2015) High prevalence of cannabis use among aka foragers of the … Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors. (Canada) (click “komornlaw” for download – 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Substituting+cannabis+for+prescription+drugs%2C+alcohol+and+other+substances+among+medical+cannabis+patients%3A+The+impact+of+contextual+factors.%22&btnG
Prescribing medical cannabis in Canada: Are we being too cautious? (Canada) (abst–2015) https://link.springer.com/article/10.17269%2Fcjph.106.4926
(1st page – 2015) https://www.questia.com/read/1P3-3836821201/prescribing-medical-cannabis-in-canada-are-we-being
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study. (USA) (abst – 2015) https://www.semanticscholar.org/paper/Association-between-cannabis-use-and-the-risk-of-Thomas-Wallner/9e5d7262609e10c514dad0ce457e7521b8deb50c
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption (Israel) (abst–2015) https://www.safetylit.org/citations/index.php?fuseaction=citations.viewdetails&citationIds%5B%5D=citjournalarticle_483021_13
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis. (USA) (abst – 2015) https://www.sciencedirect.com/science/article/pii/S0376871615016464
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students. (USA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Use of medical cannabis to reduce pain and improve quality of life in cancer patients. (Canada) (abst – 2015) http://meetinglibrary.asco.org/content/155674-165
“I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD. (USA) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156614

top
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood. (USA) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157060
Integrating cannabis into clinical cancer care. (USA) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Neuropathic Pain Treatment: Still a Challenge. (Brazil) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935814/
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869907/
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240153/
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250561/
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053858/
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population. (USA) (full – 2016) https://www.researchgate.net/publication/289970526_Effects_of_Medical_Marijuana_on_Migraine_Headache_Frequency_in_an_Ad ult_Population
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson’s disease. (Israel) (full – 2016) https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejp.942
Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization? (Israel) (link to PDF – 2016) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4045
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention. (Israel) (link to PDF– 2016) https://www.researchgate.net/publication/306434890_Cannabinoids_and_post-
traumatic_stress_disorder_clinical_and_preclinical_evidence_for_treatment_and_prevention
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study. (Israel/ USA) (link to PDF– 2016) https://www.researchgate.net/publication/295077523_The_Effect_of_Medicinal_Cannabis_on_Pain_and_Quality_of_Life_Outcomes_in_Chronic_Pain_A_Prospective_Open-label_Study
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage. (Italy) (link to PDF – 2016) https://www.researchgate.net/publication/292153451_Prior_Cannabis_Use_Is_Associated_with_Outcome_after_Intracerebral_Hemor
rhage Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage. (Italy) (link to PDF – 2016) https://www.researchgate.net/publication/292153451_Prior_Cannabis_Use_Is_Associated_with_Outcome_after_Intracerebral_Hemorrhage
No significant effect of cannabis use on the count and percentage of circulating CD4 T- cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). (France) (link to download – 2016)
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy. (USA) (click “semanticscholar” for download – 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Effects+of+Marijuana+on+ictal+and+interictal+EEG+activity+in+idiopathic+generalized+epilepsy.+++%22&btnG
The use of medical-grade cannabis in patients non-responders to Nabiximols. st (Italy) (1 page – 2016) http://www.jns-journal.com/article/S0022
-510X(16)30472-5/abstract Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies. (Germany) (abst in English & German – 2016) http://link.springer.com/article/10.1007%2Fs00482-015-0089-y
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. (Germany) (abst in English & German – 2016) https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Plant-Derived and Endogenous Cannabinoids in Epilepsy. (Italy) (abst – 2016) https://link.springer.com/article/10.1007/s40261-016-0379-x
Cannabinoids: Medical implications. (USA) (abst – 2016) https://www.semanticscholar.org/paper/Cannabinoids%3A-Medical-implications.-Schrot-
Hubbard/2aab2c83e7a45a160550cdad7a2c877e02b2c9cc Cannabis in Pain Treatment: Clinical & Research Considerations. (USA/ Canada) (abst – 2016) http://www.jpain.org/article/S1526-5900(16)00543-5/fulltext
https://www.semanticscholar.org/paper/Cannabis-in-Pain-Treatment%3A-Clinical-and-Research-Savage-Romero-Sandoval/5c366bb61590d4491e0c181640581d1e8e5105ac Metabolic syndrome in people with a psychotic illness: is cannabis protective? (Australia) (abst – 2016) https://www.semanticscholar.org/paper/Metabolic-syndrome-in-people-with-a-psychotic-is-Waterreus-Prinzio/0c8797488e049a37df455ee78a54188e1fc2fb91 Marijuana use in adults admitted to a Canadian epilepsy monitoring unit. (Canada) (abst – 2016) http://www.epilepsybehavior.com/article/S1525-5050(16)30334-1/fulltext
Contribution of health motive to cannabis use among high-school students. (France) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S0306460316302829
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis. (Canada) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27842047
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study. (USA/ Canada) (full – 2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176416
Cannabis and cognitive functioning in multiple sclerosis: The role of gender. (Canada) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468765/
How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538943/
Medical Marijuana Treatment for vismodegib-related muscle spasm. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594245/#__ffn_sectitle
Is cannabis an effective treatment for joint pain? (USA) (link to PDF- 2017) https://www.clinexprheumatol.org/abstract.asp?a=12225
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. (USA) (abst – 2017) https://www.researchgate.net/publication/314126850_Marijuana_and_other_cannabinoids_as_a_treatment_for_posttraumatic_stress_disorder_A_literature_review Cannabis and Cannabinoids for Chronic Pain. (USA) (abst – 2017) https://link.springer.com/article/10.1007%2Fs11926-017-0693-1
https://www.semanticscholar.org/paper/Cannabis-and-Cannabinoids-for-Chronic-Pain-Romero-Sandoval-Kolano/70553bf4f70581f2730facdc6714503e4f2028b4
Cannabis for the treatment of ulcerative colitis. (Canada) (full in English & Spanish – 2018) https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012954.pub2/full
Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions. (USA) (full – 2018) http://www.mdpi.com/2305-6320/5/3/75/htm
The association of therapeutic versus recreational marijuana use and antiretroviral adherence among adults living with HIV in Florida. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067624/
The Consumption of Cannabis by Fibromyalgia Patients in Israel. (Israel) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081591/
The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis. (UK) (full – 2018) https://link.springer.com/article/10.1007%2Fs11910-018-0857-z
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. (USA/ Australia) (full – 2018) https://www.nature.com/articles/s41386-018-0011-2
Cannabis Use in Individuals with Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado. (USA) (download – 2018) https://www.cedfoundation.com/wp-content/uploads/2019/10/Cannabis-Use-in-Individuals-with-Spinal-Cord-Injury-or-Moderate-to-Severe-Traumatic-Brain-Injury-in-Colorado.pdf
FDA Grants Orphan Drug Designation to Cannabis Pellet (USA) (article – 2018) https://www.practicalpainmanagement.com/treatments/pharmacological/fda-grants-orphan-drug-designation-cannabis-pellet
Pain interference and alcohol, nicotine, and cannabis use disorder in a national sample of substance users. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618301169
Should ophtalmologists recommend medical cannabis to patients with glaucoma? (Denmark) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30020072
2019 Cannabis and Cannabinoids (PDQ®) Patient Version. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK65875/
2019 Cannabis and Cannabinoids (PDQ®)Health Professional Version. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK65755/
The Association between Cannabis Product Characteristics and Symptom Relief. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389973/
A Cost-Effectiveness Model for Adjunctive Smoked Cannabis in the Treatment of Chronic Neuropathic Pain. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446169/
Safety and Efficacy of Medical Cannabis in Fibromyalgia. (Israel) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616435/
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? (Spain/ Serbia) (full – 2019) https://www.frontiersin.org/articles/10.3389/fphar.2019.00339/full
Medical Cannabis in Treatment of Resistant Familial Mediterranean Fever. (Israel) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753661/
Cannabis sativa as a Potential Treatment for Systemic Sclerosis. (Israel/ Portugal) (link to PDF – 2019) https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2019&month=03&page=217
Cannabis-based treatments as an alternative remedy for epilepsy. (USA) (article – 2019) https://www.sciencedirect.com/science/article/pii/S221342201930157X
TSFM mutations cause a complex hyperkinetic movement disorder with strong relief by st cannabinoids. (Germany) (1 page – 2019) https://www.prd-journal.com/article/S1353
-8020(18)30427-9/fulltext Cannabis for medical purposes and its prescription. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02970-6
Cannabis for medical purposes : Impact of the law of 6 March 2017 on physicians. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00482-019-0387-x
Long-term medical cannabis use and risk factors for diversion: report on physician’s guidance and patients’ behaviour. (Israel) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31190678
Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education. (Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31579835
Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31613869
An Integrated Review of Cannabis and Cannabinoids in Adult Oncologic Pain Management. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1524904218302091
Short- and Long-Term Effects of Cannabis on Headache and Migraine. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31715263
Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada. (Canada) (abst – 2019) https://jech.bmj.com/content/early/2019/12/11/jech-2019-212438.long
β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain. (Kuwait) (full – 2020) https://www.mdpi.com/1420-3049/25/1/106/htm
Is time elapsed between cannabis use and sleep start time associated with sleep continuity? An experience sampling method. (Israel) (abst – 2020) https://www.sciencedirect.com/science/article/abs/pii/S0376871620300119 


Updated 3 April 2020